	sample	numLostAlleles	normal WXS id	study_x	patient id	Age	Gender	Response	OS_x	OS.time	PFS_x	PFS.time	Biopsy Time	tumor RNA id	BCR_Shannon	TCR_Shannon	BCR_Richness	TCR_Richness	BCR_Evenness	TCR_Evenness	tumor WXS id	cancer	partial.coding	partial.sd.coding	complete.coding	partial.sd.surv.coding	nonresponder.sd.coding	response_crist_sd	response_crist_sd_surv	response_crist_partial	response_crist_complete	study_cancer	13:31310579:G:A_A	12:69824495:G:T_T	10:97468589:G:T_G	19:7792199:C:T_T	1:161582678:C:A_A	5:79834564:C:A_A	12:113481867:A:G_G	19:45020160:C:G_G	5:80291972:G:A_A	6:24550964:T:C_C	1:161508763:T:C_C	11:64885445:C:A_A	9:5452560:G:C_C	10:71880791:C:G_G	1:89525812:C:G_G	1:89513250:C:T_T	6:24534193:C:A_A	8:19233093:G:C_C	5:80278107:C:T_C	16:89734088:A:G_A	6:24501129:T:G_G	12:69639207:G:A_G	21:46329312:T:C_T	1:150456350:A:T_T	8:8999187:G:C_C	22:17582776:C:T_T	5:96202273:G:C_C	8:11338146:A:G_A	5:95979850:G:C_C	5:96216173:A:G_G	5:96200770:A:T_A	5:96194251:A:G_G	2:85787123:C:T_T	12:69825408:T:C_C	9:5459419:C:T_T	1:89498848:C:T_T	5:96206563:C:T_T	13:31312178:A:T_T	1:161279230:G:C_C	5:79893269:T:A_T	5:95768847:A:G_G	5:95818549:G:A_A	6:24560002:A:T_T	5:96032095:G:A_A	11:65704716:A:G_G	1:150527294:C:T_T	5:95894494:T:C_C	16:23669290:C:T_T	1:150861859:C:T_T	12:69794086:C:G_C	19:52263927:A:G_G	12:8210697:A:G_A	3:119372681:A:C_A	16:23719751:C:T_T	5:79681489:A:G_G	5:80232580:A:C_C	1:161445514:C:T_T	1:150558293:T:A_A	9:5453172:A:G_A	10:97390566:T:C_C	3:48720303:G:A_A	11:65838991:G:C_C	3:47672891:T:C_C	5:80120933:T:A_A	11:65157239:C:T_T	6:159050889:C:T_T	1:161592213:C:T_T	21:46336166:C:G_C	12:113421869:A:G_G	5:79955991:T:G_G	21:46328099:T:C_T	19:7789796:T:C_C	11:65718633:T:C_C	19:7772173:G:C_C	11:65644363:A:G_A	1:161388413:A:C_C	5:80362905:C:T_C	3:48591481:C:T_C	5:96132795:G:A_A	5:96085423:G:A_A	1:161572353:T:C_C	1:161565776:T:C_C	5:96118065:T:G_G	5:79596274:C:T_T	6:24399680:G:A_A	4:71742033:G:A_G	5:80215251:G:A_G	5:96147777:T:C_T	5:80294601:T:G_T	1:7921952:T:G_G	12:69739132:C:A_A	1:89363264:C:T_T	19:52159389:A:G_G	1:161597177:C:G_G	11:65824084:C:T_T	1:161617516:A:G_G	1:161606926:T:A_A	6:138070058:T:C_T	7:29186256:A:G_G	3:48198300:C:A_A	5:96034874:C:T_T	5:96374150:G:A_G	5:96224330:C:T_T	2:242793912:C:T_T	10:97447487:T:A_A	1:161477028:T:C_C	2:73903698:A:C_A	3:48245687:A:G_G	1:7927456:T:G_T	1:7833228:A:G_G	1:161511433:A:G_G	5:80212435:A:G_G	5:96391590:G:A_A	19:52281334:C:G_C	5:80229679:C:G_C	5:96152436:G:C_C	8:11273560:C:G_C	16:89858505:T:C_C	5:96055470:G:A_A	10:97630523:C:T_C	5:80279422:T:G_T	6:26370605:T:C_C	5:95826782:G:T_T	5:96403620:A:G_G	16:23621132:T:C_C	16:23607079:G:T_T	5:96103589:G:A_A	1:7969014:G:A_A	5:95969820:C:T_T	19:7764157:A:G_G	5:95975945:T:G_G	1:89735314:G:A_A	5:96201579:A:C_C	11:65412467:G:A_A	1:161494322:A:C_C	11:65645354:A:G_A	1:161646824:C:A_A	5:96182717:G:A_G	1:7908867:G:A_A	5:96096828:A:G_G	13:31315139:A:G_G	16:89843136:G:A_A	11:65585257:C:A_A	11:65583066:G:T_T	3:46451647:C:T_T	12:102119014:T:G_G	2:204731089:G:A_A	10:97643951:T:A_A	19:52276665:C:A_C	1:89385281:C:T_T	19:52151690:C:A_A	5:96229542:T:G_G	5:96738477:A:G_G	5:79606636:C:G_G	1:161515326:C:T_T	5:96114550:G:A_G	5:96028860:A:G_A	12:18242858:C:G_G	16:23692405:A:G_G	9:34549235:C:G_G	5:96122814:A:C_C	16:89625227:C:A_A	11:65614704:C:T_T	19:52242750:G:T_G	13:31341277:C:T_T	5:96143428:C:T_T	5:80296487:A:G_G	16:23698547:G:T_T	9:5468257:G:C_C	1:161484175:G:T_G	1:89113860:A:C_C	5:96353223:C:G_C	19:52123744:T:C_C	19:52129097:C:T_T	5:96198692:G:A_A	5:79889117:G:A_A	12:69671660:T:C_C	5:80212643:C:T_T	19:52132425:A:C_C	2:242795350:A:G_G	12:110857324:C:T_T	5:96198479:C:G_C	6:159072350:T:C_T	3:48446237:C:T_T	5:96074435:A:G_G	5:96527674:A:G_G	19:52222070:T:C_T	5:96147733:A:G_G	5:96159992:A:C_A	5:96151937:G:A_A	16:23549617:C:T_T	1:89478868:G:A_A	1:7836798:A:G_G	5:96185467:G:A_G	12:69735285:C:T_T	1:161557729:G:A_A	1:211545094:T:C_C	5:80391253:A:G_G	12:8204976:A:G_A	1:150958977:T:C_C	19:52249702:G:T_T	1:89356862:A:G_G	5:80171134:A:G_A	1:69151733:C:A_A	12:113342598:T:G_T	1:19402242:C:A_A	1:169930049:C:T_C	10:97361716:C:G_G	5:96120933:T:A_T	19:7763878:C:T_T	5:95801967:T:C_C	4:164471906:C:A_C	5:96170262:G:C_C	5:79646895:G:A_A	1:161575149:T:C_T	1:249111684:T:C_C	1:89242080:G:C_C	1:93870179:T:C_T	5:79946380:A:G_G	3:47587905:A:G_A	5:96293021:G:A_A	1:89473624:G:A_A	5:80194689:C:T_T	12:10480508:A:G_A	5:96376419:T:C_C	5:96109244:G:A_A	4:106521870:T:A_A	score	burden	study_y	pheno	TFH_snp	Unnamed: 0	total_muts	nonsyn_muts	clonal_muts	subclonal_muts	heterogeneity	total_neoantigens	CNA_prop	gender (Male=1, Female=0)	biopsy site	monthsBiopsyPreTx	BR	PFS_y	OS_y	TimeToBR	cyclesOnTherapy	txOngoing	Tx	Mstage (IIIC=0, M1a=1, M1b=2, M1c=3)	Tx_Start_ECOG	Tx_Start_LDH	LDH_Elevated	Brain_Met	Cut_SubQ_Met	LN_Met	Lung_Met	Liver_Visc_Met	Bone_Met	progressed	dead	Primary_Type	Histology	IOTherapy	steroidsGT10mgDaily	priorMAPKTx	priorCTLA4	postCTLA4	postMAPKTx	postCombinedCTLA_PD1	numPriorTherapies	biopsy site_categ	biopsyContext (1=Pre-Ipi; 2=On-Ipi; 3=Pre-PD1; 4=On-PD1)	daysBiopsyToPD1	daysBiopsyAfterIpiStart	purity	ploidy	individual	PHBR1	PHBR2	TMB	Escape	MHC_Class1	Ubiquitination	PT_pathway	TSGenes	Oncogenes	DNA_Repair	JAKSTAT	jakstat_long	ifng	MHC_1_list	MHC_2_list	group	Ratio
0	SRR10898098	2	SRR10898097	liu	Patient31		M	PD	1.0	426.0	1.0	85.0		SRR10900552							SRR10898098	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	0	1	0	1	0	0	1	1	0	0	1	0	0	2	1	0	1	0	1	0	0	1	1	1	0	1	0	0	1	0	0	0	1	1	1	0	1	0	1	0	1	1	0	2	0	0	2	0	1	0	0	1	0	0	0	0	1	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	1	2	0	1	0	2	1	0	2	0	0	0	0	1	0	1	0	0	0	2	1	1	0	0	0	0	1	0	1	0	0	0	0	0	0	0	1	0	1	0	0	1	1	1	0	1	0	0	2	0	0	0	0	1	1	1	0	2	1	0	1	0	0	2	1	0	0	0	1	0	0	0	0	0	0	0	2	1	0	0	0	0	0	1	1	1	1	1	0	1	0	1	1	1	0	1	1	0	2	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1	0	1	0	2	0	1	0	1	1	0	0	1	0	2	1	0	1	1	1	1	0	1	1	0	0	0	108	0.237885462555066	liu	1.0	0	Patient31	235	167	145	21	0.126506024	372	0.233946178	1	skin	0.2	PD	85	426	85	7	0	Pembrolizumab	3	0	unknown	unknown	0	1	1	1	0	1	1	1	skin	unknown	MK3475	0	0	1	0.0	0.0	0	1	skin	3	-6	214	0.88	2.97	SRR10898098	35	29	167	0	0	0	0	0	1	1	0	0	1	5	0	HLA	0.8055555555555556
1	SRR10899833	0	SRR10899968	liu	Patient147		M	CR	0.0	960.0	0.0	960.0		SRR10900553							SRR10899833	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	1	0	0	1	0	0	1	0	1	0	0	0	0	0	1	1	0	1	1	1	0	1	1	0	2	0	1	1	0	2	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	2	0	0	1	2	0	0	1	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	2	0	2	0	1	1	1	1	0	0	0	1	0	0	0	0	1	1	0	1	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	1	0	2	0	1	1	1	0	0	1	0	0	0	0	0	2	0	0	0	1	0	0	0	1	0	1	1	1	0	1	0	0	0	0	2	1	0	0	0	0	1	1	0	0	0	1	0	0	0	1	0	0	0	2	1	0	1	2	1	0	1	0	0	0	0	2	1	0	1	0	2	0	1	1	2	0	0	1	0	1	0	1	0	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	1	2	1	0	0	0	1	0	99	0.2180616740088105	liu	2.0	1	Patient147	836	542	487	39	0.074144487	1540	0.076011666	1	skin	2.2	CR	960	960	177	52	1	Nivolumab	3	0	278	1	1	1	0	1	1	0	0	0	occult		Nivolumab	0	0	0	0.0	0.0	0	0	skin	3	-66	na	0.93	2.12	SRR10899833	166	30	545	4	2	1	2	0	1	0	0	0	11	22	4	TFH	0.17964071856287425
2	SRR10899113	0	SRR10899112	liu	Patient162		M	PD	1.0	201.0	1.0	53.0		SRR10900555							SRR10899113	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	2	1	1	0	1	0	2	0	0	1	1	1	2	1	0	0	1	0	0	1	0	0	1	1	0	0	0	1	0	1	0	0	1	1	2	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	0	0	0	0	2	1	0	0	1	1	0	2	0	0	0	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	1	1	0	0	1	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	1	1	0	0	1	1	1	0	0	1	1	1	0	1	0	0	1	0	0	0	0	2	0	0	1	2	1	0	1	0	0	1	2	0	1	1	0	0	1	0	2	1	1	0	1	0	0	0	0	1	1	1	0	1	0	1	2	1	0	0	2	0	0	0	1	0	1	0	0	2	0	1	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	0	0	1	1	2	0	1	0	1	0	0	0	1	1	2	2	1	0	0	1	0	0	1	0	1	1	0	0	1	0	1	0	114	0.2511013215859031	liu	1.0	0	Patient162	2388	1566	1502	31	0.020221787	4779	0.123756314	1	intestinal metastasis	1.0	PD	53	201	53	9	0	Nivolumab	3	0	464	1	0	0	1	1	1	0	1	1	occult	na	Nivolumab	0	0	1	0.0	0.0	0	1	liver/visceral	3	-30	105	0.83	4.2	SRR10899113	331	203	1560	7	3	0	3	1	1	4	1	1	23	35	11	Neither	0.6114457831325302
3	SRR10898361	1	SRR10898950	liu	Patient204		M	CR	0.0	819.0	0.0	630.0		SRR10900589							SRR10898361	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	0	2	0	1	0	0	2	0	0	0	1	2	1	1	2	0	0	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	2	0	1	0	0	0	1	0	1	0	0	0	0	2	0	0	1	1	0	1	0	1	0	1	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	1	2	1	2	0	0	2	0	1	1	0	0	0	1	1	1	1	1	1	0	0	1	0	0	0	0	2	1	0	0	0	0	1	0	1	0	1	1	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	1	1	0	1	0	1	0	0	2	2	1	2	0	1	1	1	0	1	0	0	0	0	0	1	0	1	1	0	0	1	0	1	0	0	1	0	0	0	0	1	0	0	0	1	1	0	0	0	1	0	2	0	1	2	1	1	1	0	0	0	2	2	0	1	1	0	0	0	1	1	0	0	0	1	1	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	1	0	0	1	1	0	0	0	1	0	109	0.2400881057268722	liu	2.0	0	Patient204	2645	1772	1430	296	0.171494786	5582	0.187823806	1	skin	3.9	CR	630	819	347	39	1	Pembrolizumab	1	0	198	0	0	1	1	0	0	0	0	0	occult	occult	MK3475	0	0	0	0.0	0.0	0	0	skin	3	-117	na	0.59	3.84	SRR10898361	372	278	1930	9	2	2	2	1	1	1	1	1	20	48	9	HLA	0.7453083109919572
4	SRR10899815	3	SRR10899825	liu	Patient148		F	PR	0.0	792.0	0.0	792.0		SRR10900014							SRR10899815	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	0	1	0	0	0	1	0	1	0	0	1	1	0	0	2	1	0	1	1	1	0	0	2	1	0	0	1	0	1	0	0	1	1	1	2	0	0	1	0	1	0	0	0	0	1	1	0	0	1	1	1	1	0	1	0	0	0	1	1	0	1	1	0	0	2	1	0	0	1	0	0	0	0	0	0	0	1	0	1	1	1	1	2	1	0	1	0	0	1	0	0	1	1	1	1	1	0	1	2	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	1	2	1	0	1	0	0	0	1	0	1	1	0	0	0	0	1	2	1	0	1	2	0	0	0	0	2	2	0	1	2	1	0	0	1	0	1	2	0	0	1	0	1	0	1	1	0	0	0	1	1	1	1	0	0	0	1	0	1	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	1	0	1	1	1	0	1	1	0	0	1	0	0	1	0	1	2	0	0	0	1	0	1	0	1	1	0	1	0	117	0.2577092511013216	liu	2.0	0	Patient148	491	320	258	38	0.128378378	1103	0.252572663	0	skin	1.4	PR	792	792	156	33	1	Pembrolizumab	1	0	199	0	0	1	1	0	0	0	0	0	skin	nodular	MK3475	0	0	0	0.0	0.0	0	0	skin	3	-42	na	0.84	2.27	SRR10899815	71	53	325	2	0	0	0	0	0	0	0	0	4	5	2	HLA	0.7361111111111112
5	SRR10899836	0	SRR10899963	liu	Patient133		M	PD	1.0	370.0	1.0	63.0		SRR10842379							SRR10899836	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	1	0	1	0	0	1	1	1	1	0	1	0	1	1	1	0	0	0	0	1	0	1	1	0	0	1	0	0	1	1	1	0	1	1	0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	0	0	1	0	1	0	0	0	1	0	0	1	0	0	0	0	0	1	0	1	1	0	1	0	0	1	0	0	2	0	1	0	1	0	1	1	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	2	0	0	2	0	0	1	0	1	1	0	1	0	0	1	1	1	0	0	1	1	0	0	0	1	1	0	1	0	1	0	0	0	0	1	0	1	1	0	0	0	0	2	0	0	2	0	0	0	0	1	0	0	1	1	0	1	0	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	2	2	0	1	0	0	1	0	0	0	1	1	0	0	0	1	0	0	0	0	1	1	1	0	1	0	1	0	94	0.2070484581497797	liu	1.0	0	Patient133	518	341	256	76	0.228915663	999	0.048566109	1	skin	1.9	PD	63	370	63	3	0	Pembrolizumab	3	0	313	1	0	0	0	1	0	0	1	1	skin	LMM	Pembro	0	0	0	1.0	0.0	0	0	skin	3	-57	na	0.51	2.18	SRR10899836	112	41	365	4	0	0	0	0	1	0	0	0	7	13	0	Neither	0.36283185840707965
6	SRR10801648	2	SRR10801752	liu	Patient78		F	PD	1.0	356.0	1.0	86.0		SRR10900575							SRR10801648	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	0	1	1	0	2	1	1	1	1	0	0	1	0	0	0	1	0	1	0	0	1	0	0	1	1	2	1	0	2	0	0	2	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	1	1	0	0	1	0	1	0	0	0	0	0	0	0	1	1	0	1	0	1	0	0	1	0	1	2	0	0	0	1	1	0	0	0	1	0	1	1	0	1	1	1	1	0	0	0	0	0	0	0	2	0	0	0	0	1	0	0	0	0	0	1	1	0	1	0	0	0	1	2	0	0	0	0	0	1	0	2	0	0	0	1	0	1	0	1	1	2	1	0	1	1	0	1	0	0	2	0	0	0	2	0	0	0	0	0	0	1	1	0	0	2	1	0	1	0	1	2	0	0	0	1	0	1	0	1	1	0	0	0	1	0	2	0	0	1	0	0	0	0	1	0	0	0	0	0	0	2	2	0	1	1	0	0	1	0	0	1	1	0	0	0	0	0	0	0	1	2	2	0	1	1	2	2	0	110	0.2422907488986784	liu	1.0	0	Patient78	64	43	33	10	0.23255814	123	0.390218557	0	skin	0.7	PD	86	356	86	11	0	Pembrolizumab	2	0	178	0	0	1	0	1	0	0	1	1	skin	nmm	pembrolizumab	0	1	0	0.0	1.0	0	1	skin	3	-21	na	0.27	2.58	SRR10801648	45	38	227	0	0	0	0	0	1	1	0	0	3	4	1	HLA	0.8260869565217391
7	SRR10801754	3	SRR10801695	liu	Patient42		M	CR	0.0	1027.0	0.0	1027.0		SRR10899979							SRR10801754	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	1	1	2	1	0	0	0	0	1	1	1	0	0	1	1	1	1	0	1	0	1	0	0	0	1	1	1	1	0	1	0	0	0	1	0	0	0	1	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	2	0	0	1	0	0	1	0	0	0	1	1	1	1	0	0	1	0	2	0	0	0	1	1	1	1	0	0	1	0	1	1	0	1	0	0	2	0	2	0	1	0	1	1	0	1	0	0	0	1	0	0	1	1	2	0	0	1	0	0	1	1	0	1	0	0	1	1	1	0	0	0	0	0	2	0	1	0	1	1	0	0	0	0	0	1	2	1	0	1	1	1	0	1	0	1	0	0	0	2	1	0	0	0	0	0	1	0	0	1	1	1	1	1	0	0	1	2	0	0	0	1	1	0	1	0	1	0	0	1	0	2	0	0	1	0	1	1	1	1	0	0	0	0	0	0	2	1	0	1	0	0	0	1	1	0	1	0	1	1	1	1	1	0	0	1	1	1	0	1	0	1	2	0	120	0.2643171806167401	liu	2.0	0	Patient42	767	507	450	48	0.096385542	1610	0.123826962	1	skin	5.666666667	CR	1027	1027	83	52	1	Nivolumab	3	0	296	1	0	1	0	0	0	0	0	0	skin	nodular	Nivolumab	0	0	1	0.0	0.0	0	1	skin	1	-170	-61	0.81	2.69	SRR10801754	96	77	496	1	0	0	0	0	1	0	2	2	5	11	1	HLA	0.7938144329896907
8	SRR10868928	2	SRR10841999	liu	Patient102		M	MR	0.0	785.0	1.0	176.0		SRR10842356							SRR10868928	melanoma	1.0	2.0	1.0	1.0	1	1.0	1.0	1.0	1.0	liu	1	1	1	0	1	0	1	0	1	0	1	0	0	1	2	0	0	0	1	1	0	1	0	0	1	0	0	1	1	0	1	1	1	1	0	0	0	1	2	1	0	1	0	1	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	2	1	0	1	1	0	2	0	0	0	0	0	0	0	0	1	0	1	1	0	1	1	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	1	0	1	1	0	1	0	2	1	0	0	1	0	1	0	0	1	1	1	1	2	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	2	0	0	1	1	2	2	0	1	0	1	2	1	0	0	2	1	1	0	2	0	0	1	1	1	1	0	1	1	1	0	0	0	1	1	1	1	1	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	1	0	1	1	1	2	2	0	1	1	0	0	0	0	0	1	1	0	0	0	1	0	113	0.2488986784140969	liu	2.0	0	Patient102	370	246	215	26	0.107883817	825	0.169389493	1	brain	2.1	MR	176	785	98	8	0	Pembrolizumab	3	0	212	1	0	0	1	0	0	0	1	0	acral	unknown	MK3475	1	0	0	0.0	0.0	0	0	brain	3	-64	na	0.7	3.24	SRR10868928	52	40	241	1	1	0	1	0	1	1	1	1	1	18	4	HLA	0.7547169811320755
9	SRR10801683	3	SRR10801677	liu	Patient82		M	PD	1.0	131.0	1.0	89.0		SRR10899980							SRR10801683	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	0	1	1	0	1	0	0	2	0	1	1	0	1	1	1	0	1	1	1	0	1	1	1	2	0	1	2	0	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	2	1	0	1	1	1	1	1	2	0	0	1	0	0	0	0	1	1	0	0	2	2	0	0	0	0	0	1	0	1	0	1	1	1	0	0	2	1	0	0	0	1	1	0	1	0	1	2	2	0	0	0	1	2	1	0	0	1	1	0	1	0	1	0	0	0	1	0	0	0	0	2	2	0	0	0	1	0	1	1	0	0	1	0	1	0	0	1	1	1	1	0	0	1	2	1	1	1	1	0	0	1	1	1	0	2	1	1	0	1	1	0	0	0	1	0	0	0	0	0	1	1	0	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	2	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	1	1	0	1	0	0	0	0	1	2	1	2	0	0	0	0	0	0	1	1	0	0	0	1	1	1	122	0.2687224669603524	liu	1.0	1	Patient82	2253	1477	1390	48	0.033379694	4650	0.20502101	1	brain	42.0	PD	89	131	89	4	0	Pembrolizumab	3	1	1195	1	1	0	0	1	1	0	1	1	occult	na	Pembro	0	1	1	1.0	1.0	0	3	brain	1	-1260	-620	0.84	4.08	SRR10801683	344	288	1616	5	1	1	1	0	1	1	2	2	19	39	5	Interactors	0.8347826086956521
10	SRR10801750	0	SRR10801656	liu	Patient45		M	PR	0.0	1666.0	0.0	1666.0		SRR10900548							SRR10801750	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	0	0	0	2	0	1	0	1	1	2	0	1	0	0	1	1	0	0	0	0	1	2	0	0	0	1	0	1	1	0	0	0	1	1	1	0	1	2	0	0	0	1	0	0	1	1	0	1	1	2	0	0	1	0	0	1	0	1	0	0	0	2	0	0	2	0	0	0	1	0	0	0	0	1	0	1	0	2	0	0	0	0	0	0	1	1	0	0	1	1	1	1	0	1	0	0	1	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	1	0	0	2	0	0	2	1	1	0	0	1	2	1	1	0	0	1	2	1	0	1	1	1	0	1	2	0	0	1	0	1	1	2	0	1	0	1	1	0	0	0	1	1	2	2	1	1	1	1	0	0	0	1	0	1	1	0	1	0	0	0	0	1	0	0	0	0	2	0	0	0	0	1	1	0	0	0	1	1	0	1	2	0	0	0	1	0	0	0	0	2	0	0	0	0	1	0	0	1	0	1	2	1	2	0	120	0.2643171806167401	liu	2.0	0	Patient45	423	293	219	71	0.244827586	793	0.216010791	1	skin	0.8	PR	1666	1666	185	120	1	Nivolumab	3	0	278	1	0	0	1	1	1	0	0	0	skin	unk	Nivolumab	0	0	1	0.0	0.0	0	3	skin	3	-23	310	0.61	2.08	SRR10801750	68	43	301	2	0	0	0	0	1	0	2	2	4	4	3	Neither	0.6231884057971014
11	SRR10801693	1	SRR10801751	liu	Patient51		M	PR	0.0	1547.0	1.0	471.0		SRR10900576							SRR10801693	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	2	1	0	1	1	0	0	1	0	1	1	1	0	1	1	0	0	2	0	0	1	1	0	1	2	0	2	0	1	1	1	2	0	1	1	0	0	0	0	0	1	0	1	0	1	0	0	1	1	0	0	1	0	0	0	0	1	1	1	0	0	0	0	0	1	0	1	0	0	1	0	2	0	2	0	0	1	0	1	0	0	2	1	0	0	0	1	0	1	0	0	1	0	2	1	1	0	1	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	2	1	1	1	0	0	0	0	1	1	0	2	0	2	0	0	0	0	0	2	1	0	2	1	0	0	2	1	1	0	1	1	0	0	0	0	0	2	0	2	1	1	0	0	1	0	0	2	0	0	1	0	1	0	0	2	2	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	1	2	0	0	1	1	1	0	1	1	1	2	1	1	0	1	0	0	0	0	1	0	1	0	0	0	0	0	118	0.2599118942731278	liu	2.0	0	Patient51	1723	1134	989	112	0.101725704	3069	0.15900598	1	skin	1.3	PR	471	1547	56	34	0	Nivolumab	2	0	185	0	0	0	0	1	0	0	1	0	skin	SSM	Nivo	0	0	0	0.0	0.0	0	0	skin	3	-38	na	0.3	3.82	SRR10801693	309	221	1146	6	1	1	1	0	1	0	2	2	17	29	7	HLA	0.7129032258064516
12	SRR10801701	0	SRR10801711	liu	Patient87		F	PR	0.0	1263.0	1.0	1142.0		SRR10900596							SRR10801701	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	1	2	0	0	0	0	0	0	1	0	2	0	2	1	1	1	1	0	1	1	0	1	1	0	1	0	0	2	0	2	1	0	1	0	0	0	0	1	0	0	0	1	0	0	2	0	0	2	0	0	1	0	2	0	1	0	0	0	1	0	0	0	1	1	1	2	1	1	0	1	0	2	0	2	0	0	0	0	1	0	2	2	1	1	0	1	0	0	0	0	0	2	2	2	0	0	1	1	1	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	1	1	0	0	0	0	0	0	1	0	1	1	0	1	0	0	0	2	0	1	0	0	0	1	0	0	0	0	0	0	0	1	2	0	2	2	0	1	1	2	1	0	2	1	0	1	0	0	1	0	2	2	1	2	0	0	0	0	0	2	0	1	0	0	1	0	0	0	1	0	0	0	1	1	0	0	1	0	0	0	1	0	1	1	0	1	0	0	2	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	119	0.2621145374449339	liu	2.0	1	Patient87	121	87	72	14	0.162790698	222	0.251171185	0	skin	0.466666667	PR	1142	1263	85	22	0	Pembrolizumab	3		343	1	0	0	1	0	0	1	1	0	occult	unknown	MK3475	0	0	1	0.0	0.0	0	1	skin	3	-14	335	0.36	3.48	SRR10801701	21	14	94	0	0	0	0	0	0	0	0	0	3	6	1	TFH	0.6363636363636364
13	SRR10899807	0	SRR10899971	liu	Patient117		F	PD	1.0	295.0	1.0	100.0		SRR10842367							SRR10899807	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	0	0	2	1	1	1	1	1	1	1	1	0	0	0	0	1	1	1	1	0	0	1	0	1	1	0	1	0	0	1	1	1	1	0	0	1	0	1	0	1	0	1	0	0	0	0	0	0	0	0	2	1	1	0	0	1	0	0	0	0	2	1	0	0	1	0	2	0	1	1	2	0	2	0	1	0	0	0	1	0	0	2	1	0	0	2	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	1	0	1	0	1	0	0	0	1	0	0	0	0	2	1	0	1	2	0	0	0	0	1	1	0	0	2	2	1	0	2	0	1	1	1	0	1	2	1	1	0	0	1	0	2	0	0	1	0	0	0	1	1	2	1	0	0	0	1	0	0	0	0	1	0	0	1	0	1	1	0	0	0	0	0	0	1	0	1	1	0	0	2	2	1	0	2	1	0	0	0	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	1	2	0	1	1	116	0.2555066079295154	liu	1.0	1	Patient117	47	34	17	14	0.451612903	110	0.392475013	0	soft tissue	0.4	PD	100	295	100	6	0	Pembrolizumab	3	0	275	1	0	1	0	0	0	0	1	1	skin	nodulair	MK3475	0	0	1	0.0	0.0	0	2	soft tissue	3	-12	306	0.33	1.88	SRR10899807	12	6	57	1	1	0	1	0	0	0	0	0	1	3	0	TFH	0.46153846153846156
14	SRR10801707	1	SRR10801663	liu	Patient4		M	CR	1.0	600.0	1.0	574.0		SRR10900012							SRR10801707	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	0	0	1	0	0	0	0	0	1	0	0	0	1	1	0	2	0	0	1	0	0	1	0	0	0	0	0	1	0	0	1	1	1	2	1	1	0	0	2	0	1	0	0	1	0	0	0	0	0	1	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	1	0	1	0	0	1	0	1	1	0	1	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	1	1	0	0	1	1	0	1	0	0	0	0	1	0	2	0	1	0	0	1	0	1	0	0	0	0	0	0	0	2	0	0	1	1	0	0	0	0	1	1	0	0	1	1	0	0	1	1	0	0	1	0	2	0	0	0	1	0	0	1	1	0	1	1	0	0	1	0	1	1	0	1	1	0	1	0	0	2	0	1	0	0	2	0	2	0	1	1	0	0	0	0	0	0	1	0	0	0	0	1	1	1	0	1	0	0	0	1	1	0	0	0	0	0	1	1	0	0	0	1	0	0	0	2	0	1	0	91	0.2004405286343612	liu	2.0	0	Patient4	603	384	314	53	0.144414169	1321	0.121665383	1	skin	5.1	CR	574	600	151	26	0	Pembrolizumab	3	0	149	0	0	1	1	1	1	0	1	1	skin	not classified	MK3475	no	0	1	0.0	0.0	0	2	skin	1	-154	-106	0.88	2.03	SRR10801707	88	47	398	1	2	1	2	1	1	0	1	1	5	16	2	HLA	0.5280898876404494
15	SRR10898937	3	SRR10898317	liu	Patient197		F	PR	0.0	960.0	1.0	89.0		SRR10900551							SRR10898937	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	1	1	1	0	0	1	0	1	0	0	0	0	0	1	1	1	0	0	1	0	0	0	1	0	2	0	1	0	0	2	1	1	1	0	1	0	0	1	0	0	0	0	0	0	2	0	0	2	1	0	1	0	0	1	1	0	2	0	1	0	0	1	1	0	1	1	0	0	0	0	1	1	1	1	0	0	2	0	1	0	1	1	0	0	1	1	0	0	0	0	0	0	1	0	1	1	2	1	0	0	0	0	0	0	0	0	1	2	1	0	0	0	0	1	0	1	1	1	1	0	2	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	1	1	1	0	0	1	1	0	0	0	1	1	0	1	1	0	1	1	1	0	1	0	0	0	1	1	0	1	0	2	1	0	0	0	0	1	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	2	0	0	1	0	0	1	0	1	0	1	0	0	1	0	0	0	0	0	0	1	0	1	0	1	0	101	0.2224669603524229	liu	2.0	0	Patient197	90	59	45	7	0.134615385	185	0.447039513	0	brain	2.166666667	PR	89	960	147	66	1	Nivolumab	3	1	295	1	1	0	0	1	0	0	1	0	skin	nodular	Nivolumab	0	0	0	0.0	0.0	0	0	brain	3	-65	na	0.81	2.59	SRR10898937	11	10	69	1	0	0	0	0	1	0	0	0	1	8	0	HLA	0.8333333333333334
16	SRR10899715	1	SRR10899899	liu	Patient126		M	PR	0.0	992.0	1.0	742.0		SRR10842369							SRR10899715	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	0	2	0	0	1	0	0	1	0	1	1	1	2	1	1	0	0	1	0	0	1	1	0	0	1	0	0	1	0	1	2	0	0	1	0	1	0	1	0	0	0	0	1	0	2	1	0	1	0	1	2	1	2	0	0	0	0	1	0	0	1	2	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	1	2	1	0	2	0	0	0	1	0	1	0	1	1	2	0	1	1	1	1	1	1	1	1	0	0	2	0	0	0	1	1	1	0	1	0	1	0	1	0	0	2	1	2	0	0	1	0	0	1	1	1	0	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	1	1	0	2	0	2	0	0	0	0	0	1	0	0	0	0	1	0	0	1	0	0	1	0	2	0	1	0	0	2	2	1	1	0	0	0	0	0	0	1	0	0	1	2	0	0	0	1	0	2	0	0	2	1	1	0	0	0	0	2	0	0	0	0	0	1	1	1	1	0	0	0	117	0.2577092511013216	liu	2.0	0	Patient126	973	656	553	82	0.129133858	1862	0.070364788	1	skin	0.2	PR	742	992	223	30	0	Nivolumab	3	0	172	0	0	1	1	1	0	1	1	0	occult	x	Nivolumab	0	0	0	0.0	0.0	0	0	skin	3	-5	na	0.64	3.09	SRR10899715	114	98	635	2	0	0	0	0	1	2	0	0	10	18	2	HLA	0.8521739130434782
17	SRR10868927	3	SRR10842094	liu	Patient10		F	PR	1.0	1139.0	1.0	169.0		SRR10842352							SRR10868927	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	0	2	0	0	0	1	1	0	1	0	1	0	1	0	1	1	0	1	0	1	0	1	1	1	0	1	1	0	1	1	1	1	0	0	0	0	0	2	1	1	0	1	1	1	1	0	1	0	0	0	0	1	2	0	0	0	0	0	0	0	0	1	0	0	1	1	1	0	1	1	1	1	1	1	1	1	2	1	1	0	1	0	1	1	0	1	0	0	1	1	1	0	1	1	0	0	0	1	1	0	1	1	0	0	0	1	1	1	1	0	0	0	1	0	0	1	0	1	0	0	1	0	1	0	0	0	1	0	2	0	1	0	0	0	1	0	1	1	1	0	0	1	1	0	1	1	0	1	0	0	0	1	1	0	0	1	1	0	0	0	0	1	1	0	2	1	0	1	2	1	1	1	0	0	0	0	1	1	0	1	0	0	0	1	0	0	0	0	1	0	1	0	0	1	0	1	0	0	1	2	1	1	1	0	0	1	0	1	1	1	0	1	1	0	0	0	0	1	1	1	0	1	1	1	1	0	125	0.2753303964757709	liu	2.0	0	Patient10	96	71	48	22	0.314285714	230	0.391383951	0	skin	0.4	PR	169	1139	81	1	0	Pembrolizumab	3	1	2186	1	0	1	1	1	1	1	1	1	skin	x	MK3475	1	1	1	1.0	1.0	0	2	skin	3	-12	107	0.83	1.84	SRR10868927	13	13	70	0	0	0	0	0	1	0	1	1	0	1	0	HLA	0.9285714285714286
18	SRR10898307	2	SRR10898936	liu	Patient159		F	SD	0.0	288.0	1.0	216.0		SRR10900565							SRR10898307	melanoma	1.0	2.0	1.0	1.0	2	2.0	1.0	1.0	1.0	liu	0	1	0	1	0	0	1	0	1	1	1	0	0	1	1	0	1	0	1	1	0	0	1	1	1	0	0	0	1	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1	1	1	2	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	1	1	1	0	1	1	0	1	0	1	0	2	0	0	0	1	1	0	1	1	0	1	0	1	0	1	1	1	0	0	0	0	1	0	1	0	0	0	0	0	0	1	1	1	0	0	1	0	1	1	1	0	0	1	0	0	0	0	1	0	1	1	2	1	0	0	2	0	1	0	0	2	1	0	0	0	1	1	0	1	0	0	1	1	1	0	1	1	0	1	2	0	1	0	1	0	1	0	0	0	2	0	0	1	1	0	1	0	2	0	0	1	1	1	0	1	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	0	1	0	0	0	0	1	2	0	1	0	0	1	0	0	1	0	1	2	1	0	1	0	1	1	109	0.2400881057268722	liu	2.0	0	Patient159	66	46	31	13	0.295454545	204	0.280752813	0	maxillary sinus, hard palate	6.833333333	SD	216	288	62	12	0	Pembrolizumab	3	1	242	0	0	0	1	0	1	1	1	0	mucosal	na	MK3475	0	0	1	0.0	0.0	0	1	bone	1	-205	-118	0.78	2.92	SRR10898307	6	10	64	0	0	0	0	0	0	0	0	0	1	1	0	HLA	1.4285714285714286
19	SRR10801647	0	SRR10801649	liu	Patient75		M	PR	0.0	891.0	1.0	891.0		SRR10900562							SRR10801647	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	1	1	1	1	1	0	1	0	1	0	1	0	0	1	0	2	0	0	1	1	0	1	1	1	0	1	0	0	0	0	2	2	0	0	0	1	0	1	1	1	0	0	0	0	1	0	0	1	0	1	0	0	0	1	0	1	1	0	0	1	0	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	1	1	0	2	0	1	2	0	0	0	2	0	0	1	0	1	0	1	1	0	0	1	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	1	0	2	2	0	0	2	1	2	1	0	0	1	0	1	2	0	0	0	0	2	0	2	0	1	0	1	0	0	0	1	2	1	0	0	0	1	1	1	1	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	1	2	0	0	0	0	0	0	0	100	0.2202643171806167	liu	2.0	0	Patient75	1112	725	645	62	0.087694484	2304	0.201142567	1	skin	0.2	PR	891	891	78	15	0	Nivolumab	3	3	254	1	0	1	0	1	0	0	1	0	occult	na	nivolumab	0	0	0	0.0	0.0	0	0	skin	3	-6	na	0.55	3.76	SRR10801647	254	71	743	3	0	0	0	1	1	2	0	0	12	18	7	Neither	0.2784313725490196
20	SRR10868926	0	SRR10841991	liu	Patient100		F	PR	1.0	938.0	0.0	922.0		SRR10842349							SRR10868926	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	1	0	1	0	0	0	1	1	1	1	0	1	1	1	1	1	1	0	1	1	0	2	0	0	0	1	1	1	0	1	1	1	1	1	1	0	0	1	0	1	1	0	0	0	0	1	0	2	1	2	0	0	1	2	2	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	1	0	1	0	2	2	1	1	0	0	0	0	0	0	1	2	1	1	0	0	0	2	1	0	0	1	1	0	1	0	1	1	1	0	0	0	0	0	0	1	1	1	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	0	0	1	2	1	1	0	2	0	1	1	0	1	0	0	0	0	2	0	0	1	1	0	1	0	1	1	1	1	0	0	0	0	0	0	0	1	1	0	0	0	1	1	1	0	0	0	2	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	1	0	109	0.2400881057268722	liu	2.0	0	Patient100	200	126	98	24	0.196721311	301	0.02944673	0	skin	3.1	PR	922	938	75	43	1	Nivolumab	3	1	313	1	0	1	1	0	0	0	0	1	occult	unknown	Nivolumab	0	0	1	0.0	0.0	0	1	skin	3	-94	33	0.11	2.17	SRR10868926	35	18	149	1	0	0	0	0	0	0	0	0	0	6	1	Neither	0.5
21	SRR11080170	0	SRR10899919	liu	Patient142		F	SD	0.0	996.0	0.0	996.0		SRR10899955							SRR11080170	melanoma	1.0	2.0	1.0	2.0	1	2.0	2.0	1.0	1.0	liu	1	0	2	0	0	0	0	0	2	0	1	0	0	0	2	0	0	0	1	0	1	0	1	2	1	2	0	1	2	1	0	0	2	0	0	0	1	1	0	0	1	0	0	0	0	2	0	0	2	0	0	1	2	1	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	1	1	0	0	0	0	1	1	0	0	0	0	1	2	0	1	0	1	2	0	0	1	1	2	1	2	0	0	1	0	1	0	0	0	0	0	0	0	1	1	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	2	1	0	0	1	2	1	0	0	0	1	2	1	0	2	2	0	0	0	0	1	1	2	0	1	1	0	2	2	0	1	0	0	0	1	1	1	0	1	0	0	1	1	0	0	1	1	1	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	1	1	1	0	1	0	0	0	0	0	0	0	0	0	2	0	1	0	0	1	1	1	2	1	0	0	0	0	1	117	0.2577092511013216	liu	2.0	0	Patient142	73	48	37	10	0.212765957	198	0.117839207	0	skin	1.333333333	SD	996	996	98	31	1	Pembrolizumab	1	0	181	0	0	1	0	0	0	0	0	0	skin	nodular	MK3475	0	0	0	0.0	0.0	0	0	skin	3	-40	na	0.62	3.41	SRR11080170	16	5	62	0	0	0	0	0	1	0	0	0	1	5	1	Neither	0.29411764705882354
22	SRR10898085	0	SRR10898062	liu	Patient35		M	SD	1.0	968.0	1.0	181.0		SRR10899977							SRR10898085	melanoma	1.0	2.0	1.0	2.0	1	2.0	2.0	1.0	1.0	liu	1	0	0	1	0	1	1	1	1	0	0	0	0	0	0	1	1	0	0	0	0	0	1	1	1	0	0	2	0	0	2	1	2	1	0	1	0	1	0	1	0	0	1	0	2	1	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	2	1	1	1	0	1	1	0	1	0	0	0	1	0	2	1	1	1	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	1	1	0	0	0	0	0	2	0	0	0	0	0	0	0	1	0	0	2	0	2	1	1	1	0	0	0	0	0	0	0	1	1	1	0	1	0	0	0	1	2	0	1	0	1	1	0	0	1	0	1	1	1	0	2	1	0	1	0	0	0	0	1	0	1	1	1	1	1	0	0	1	0	2	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	1	1	1	0	0	0	0	1	1	0	1	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	100	0.2202643171806167	liu	2.0	0	Patient35	65	40	27	12	0.307692308	112	0.162618152	1	skin	2.1	SD	181	968	93	13	0	Nivolumab	3	0	216	0	0	1	1	0	1	0	1	1	skin	nodular	Nivolumab	0	0	1	1.0	0.0	1	2	skin	3	-63	536	0.77	2.15	SRR10898085	19	7	56	2	0	0	0	0	0	0	0	0	1	7	0	Neither	0.35
23	SRR10801676	1	SRR10801659	liu	Patient77		F	PD	1.0	444.0	1.0	95.0		SRR10899985							SRR10801676	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	0	1	0	1	1	0	0	1	0	1	0	1	1	0	1	0	2	0	2	0	0	1	0	0	0	0	0	1	1	1	1	0	0	2	1	0	1	1	0	0	1	0	0	0	1	0	0	0	1	0	0	1	0	0	0	1	0	2	0	0	0	1	0	0	2	0	0	0	1	0	0	0	0	0	0	1	1	0	2	1	1	1	0	0	0	1	0	1	0	1	1	0	0	1	0	0	1	0	1	0	1	0	1	1	1	0	0	1	0	0	1	0	1	1	0	0	2	2	1	0	0	0	0	0	0	0	1	0	2	1	0	0	1	1	0	1	1	0	0	1	1	2	2	0	1	0	1	1	0	0	0	1	1	1	1	0	0	0	0	1	2	1	1	1	1	0	0	1	0	1	1	1	1	0	1	0	1	2	1	0	0	0	0	0	1	0	0	0	0	1	0	0	1	1	1	1	1	0	1	1	0	1	1	0	1	0	1	1	0	1	1	0	0	1	0	0	0	1	0	1	0	0	1	0	0	0	119	0.2621145374449339	liu	1.0	2	Patient77	151	92	67	19	0.220930233	201	0.180587685	0	lung	15.3	PD	95	444	95	13	0	Pembrolizumab	3	0	228	0	1	0	0	1	0	0	1	1	skin	ssm	pembrolizumab	1	0	0	0.0	1.0	0	0	lung	3	-459	na	0.74	1.98	SRR10801676	29	9	94	2	0	0	0	0	1	0	0	0	1	5	0	Interactors	0.3
24	SRR10899824	1	SRR10899818	liu	Patient135		M	CR	0.0	628.0	0.0	628.0		SRR10842371							SRR10899824	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	0	0	1	0	0	1	1	1	0	1	2	1	0	1	0	1	1	1	0	1	0	1	1	0	2	0	1	2	1	1	0	0	0	1	0	1	0	0	1	0	1	1	1	0	1	1	0	0	0	2	1	0	2	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	1	1	1	0	0	0	0	0	2	0	0	1	0	1	0	0	0	0	1	0	1	1	1	0	2	0	0	0	1	0	0	0	0	1	0	0	1	0	1	1	1	0	2	0	1	1	0	1	0	0	0	0	1	0	1	1	0	0	1	2	1	0	0	1	0	1	0	0	1	1	0	0	2	1	1	0	1	0	1	1	0	1	1	0	0	1	1	0	0	0	0	0	1	0	0	0	1	0	0	1	1	0	0	1	0	2	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	1	0	1	1	0	0	2	0	2	1	0	1	0	2	0	0	0	0	1	2	0	0	0	1	1	0	112	0.2466960352422907	liu	2.0	1	Patient135	578	388	341	30	0.080862534	1137	0.030461458	1	skin	2.433333333	CR	628	628	91	28	1	Pembrolizumab	3	0	287	1	0	0	1	1	0	0	0	0	skin	SSM	Pembro	0	0	0	0.0	0.0	0	0	skin	3	-73	na	0.78	2.07	SRR10899824	93	62	404	3	1	1	1	1	0	0	0	0	10	13	1	Interactors	0.6595744680851063
25	SRR10801658	2	SRR10801689	liu	Patient72		M	PD	0.0	395.0	1.0	67.0		SRR10899991							SRR10801658	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	1	1	0	0	0	0	0	1	0	1	0	0	0	0	2	1	1	1	0	0	1	0	1	1	1	0	1	1	0	0	0	1	0	0	0	0	0	0	2	2	0	0	0	0	2	0	0	2	2	0	0	0	2	1	0	0	0	0	1	0	0	1	1	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	1	0	1	1	0	0	0	0	1	0	2	0	0	1	1	1	0	0	0	0	0	1	1	0	1	0	1	0	1	1	1	0	1	0	1	1	0	2	1	0	0	0	1	1	1	1	0	0	1	2	0	0	1	2	0	0	0	0	1	1	1	0	0	1	2	0	0	0	2	1	0	1	2	0	1	0	1	0	0	1	0	0	1	0	0	0	0	0	0	1	1	0	0	1	0	0	0	1	1	0	0	1	0	0	1	0	0	1	0	1	0	0	0	0	0	0	1	0	1	0	1	1	0	1	1	2	0	1	0	0	2	0	1	0	1	1	2	0	0	0	0	1	0	110	0.2422907488986784	liu	1.0	1	Patient72	184	121	103	15	0.127118644	371	0.171137069	1	skin	4.0	PD	67	395	67	0	0	Nivolumab	1	0	216	0	0	1	0	0	0	0	1	0	skin	SSM	nivolumab	0	0	1	0.0	1.0	0	2	skin	3	-119	240	0.78	3.89	SRR10801658	27	18	135	0	0	1	0	0	1	0	0	0	2	3	4	Interactors	0.6428571428571429
26	SRR10899006	1	SRR10898370	liu	Patient163		M	PD	1.0	173.0	1.0	48.0		SRR10899974							SRR10899006	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	2	0	0	1	0	0	2	0	0	1	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	2	0	0	0	0	0	0	0	0	0	1	0	0	1	2	0	0	0	0	0	0	0	1	0	0	0	1	0	0	2	0	0	0	0	0	0	1	0	0	1	1	2	0	0	0	1	0	1	0	1	1	0	0	0	0	0	0	0	0	0	1	0	1	0	1	1	0	0	0	1	0	0	0	0	0	1	0	0	0	1	1	1	0	1	0	0	0	2	0	0	1	1	0	0	2	0	0	0	1	0	1	0	0	0	0	0	0	1	0	0	0	1	0	1	1	0	0	2	1	1	1	0	1	0	0	1	1	2	0	0	1	0	2	2	0	1	0	1	0	2	0	0	0	0	0	1	0	0	2	1	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	1	0	2	0	85	0.1872246696035242	liu	1.0	0	Patient163	305	201	180	12	0.0625	470	0.193168456	1	lymph node	10.26666667	PD	48	173	48	9	0	Nivolumab	3	1	253	1	0	1	1	0	0	1	1	1	occult	na	Nivolumab	0	1	1	0.0	1.0	1	3	lymph node	1	-308	-22	0.83	2.82	SRR10899006	42	28	230	1	0	0	0	0	1	0	0	0	8	16	1	HLA	0.6511627906976745
27	SRR10899839	3	SRR10899828	liu	Patient158		M	PR	0.0	194.0	1.0	162.0		SRR10900561							SRR10899839	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	1	1	2	2	0	0	1	0	0	0	1	1	0	0	1	1	1	0	0	1	0	1	0	0	0	1	1	0	0	1	1	0	1	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	1	0	1	2	2	0	0	0	0	0	1	0	0	1	0	0	1	0	0	0	0	0	0	0	2	0	0	0	1	0	0	0	0	1	0	0	0	1	0	1	1	0	0	0	0	0	1	1	1	2	1	0	1	1	0	1	1	0	1	1	0	1	0	0	1	1	0	0	1	0	2	0	2	0	0	0	0	0	1	0	2	0	0	0	1	0	0	0	1	1	2	0	1	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	1	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	2	0	1	0	0	1	0	2	1	0	1	0	0	0	0	1	0	0	0	0	1	1	1	1	0	0	1	0	0	0	2	0	1	1	1	0	0	1	0	2	0	0	0	1	1	0	2	1	2	0	104	0.2290748898678414	liu	2.0	0	Patient158	3618	2296	1951	303	0.134427684	6776	0.1579233	1	adrenal gland	7.0	PR	162	194	62	0	0	Pembrolizumab	3	1	457	1	0	0	1	0	1	0	1	0	skin	x	pembrolizumab	0	1	0	0.0	0.0	0	1	liver/visceral	3	-210	na	0.75	1.99	SRR10899839	506	335	2277	5	3	2	3	3	1	3	2	2	28	52	15	HLA	0.6607495069033531
28	SRR10899941	0	SRR10899954	liu	Patient140		M	PD	1.0	351.0	1.0	67.0		SRR10842381							SRR10899941	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	1	1	2	1	0	1	0	0	1	2	0	0	0	0	1	1	1	0	0	1	0	1	2	1	1	0	1	0	0	2	2	1	0	0	1	0	0	2	0	1	0	1	1	0	1	0	0	1	1	1	1	0	2	0	0	1	1	0	0	0	0	0	0	1	2	0	0	0	0	0	2	1	1	1	1	0	1	0	2	0	0	2	0	1	0	0	0	1	1	0	1	1	0	0	0	0	1	2	0	1	1	0	0	0	0	1	2	0	0	0	0	1	0	1	0	0	1	0	0	0	0	1	0	0	0	0	1	0	2	0	0	0	0	2	0	0	0	1	0	0	0	0	0	0	1	2	0	0	0	0	0	1	0	1	1	1	1	0	0	2	0	0	1	0	0	0	0	0	0	1	2	0	0	0	0	0	1	0	1	0	0	0	0	2	0	1	0	0	0	1	0	0	0	0	1	0	1	1	1	1	1	0	0	0	1	0	0	1	2	1	0	0	0	1	0	0	0	0	2	0	1	0	0	0	0	0	111	0.2444933920704846	liu	1.0	1	Patient140	3077	2077	1837	193	0.095073892	6997	0.188948385	1	skin	1.733333333	PD	67	351	67	3	0	Pembrolizumab	2	1	125	0	0	0	0	1	0	0	1	1	skin	NOS	Pembro	0	0	0	1.0	0.0	0	0	skin	3	-52	na	0.94	1.9	SRR10899941	606	195	2039	7	3	1	3	1	0	0	0	0	27	47	7	TFH	0.3212520593080725
29	SRR10898957	2	SRR10898318	liu	Patient181		F	CR	0.0	476.0	0.0	476.0		SRR10899981							SRR10898957	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	1	1	1	0	0	0	0	0	1	1	1	0	0	1	0	1	2	0	0	1	1	0	1	0	0	1	0	0	0	0	2	2	1	0	0	1	0	1	0	1	0	0	1	2	0	0	0	0	0	0	1	1	1	2	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	2	1	2	1	0	1	0	2	0	1	1	0	1	0	0	0	0	0	0	1	2	0	1	0	0	0	0	1	0	1	0	0	0	0	1	1	1	1	0	0	1	0	1	0	0	1	2	1	1	1	0	0	1	0	0	0	0	1	0	0	0	0	1	1	0	1	0	0	1	1	0	0	0	1	1	0	1	0	1	0	1	0	0	1	2	0	0	1	1	0	0	0	1	1	0	0	0	1	1	2	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	1	0	0	0	1	1	0	0	0	2	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	99	0.2180616740088105	liu	2.0	0	Patient181	409	275	217	38	0.149019608	757	0.333306508	0	skin	0.666666667	CR	476	476	84	17	1	Nivolumab	3	0	249	1	0	1	0	1	0	0	0	0	skin	SSM 	Nivolumab 	0	0	0	0.0	0.0	0	0	skin	3	-20	na	0.64	1.98	SRR10898957	82	26	306	3	1	0	1	1	1	0	0	0	7	14	0	HLA	0.3132530120481928
30	SRR10801665	0	SRR10801654	liu	Patient98		F	PD	1.0	683.0	1.0	73.0		SRR10900584							SRR10801665	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	2	1	0	2	0	2	0	2	0	0	1	0	0	0	2	0	0	1	1	0	0	0	1	2	1	0	2	0	0	1	1	1	0	0	0	1	1	0	1	1	0	0	0	2	1	0	0	1	0	0	1	2	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	1	1	0	0	1	1	0	0	0	0	1	0	0	0	0	0	2	1	0	2	0	1	1	0	1	0	0	0	0	0	1	0	1	0	1	1	1	1	1	2	0	0	1	1	0	0	1	0	0	1	1	0	0	0	2	1	0	0	1	0	2	2	0	2	0	1	1	0	1	1	1	1	0	2	1	0	1	1	1	1	2	0	1	0	1	1	0	0	0	1	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	1	0	0	1	2	0	0	0	1	1	0	1	1	0	1	0	1	0	0	1	1	0	0	1	0	0	0	0	114	0.2511013215859031	liu	1.0	0	Patient98	472	302	219	74	0.252559727	790	0.223074401	0	lung	0.8	PD	73	683	73	28	0	Nivolumab	2	0	192	0	0	0	1	1	0	0	1	1	occult		Nivolumab	1	0	0	0.0	0.0	1	0	lung	3	-24	na	0.6	1.99	SRR10801665	87	45	314	2	0	0	0	0	1	0	1	1	8	3	1	Neither	0.5113636363636364
31	SRR10898375	2	SRR10898371	liu	Patient183		M	PD	1.0	572.0	1.0	84.0		SRR10900011							SRR10898375	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	2	0	1	0	0	0	1	0	0	0	1	0	0	1	0	1	1	0	0	0	0	0	0	1	0	0	0	0	1	0	1	0	0	1	2	2	1	0	2	0	1	0	1	0	0	0	0	1	0	0	1	1	1	0	0	0	0	0	0	1	1	2	1	0	2	0	1	1	1	0	0	2	1	0	1	0	0	1	1	0	1	1	0	0	0	1	2	0	0	0	0	0	1	0	0	1	1	2	0	0	0	0	1	1	0	0	1	0	0	1	1	0	2	1	2	0	1	1	0	0	1	0	1	1	0	0	0	1	1	0	0	2	2	0	0	0	0	2	1	0	2	1	0	1	0	1	0	1	0	1	0	1	0	0	1	0	2	0	0	1	0	0	1	0	0	0	0	0	0	1	0	1	0	1	0	0	1	1	1	0	0	0	0	1	1	0	0	1	1	2	0	0	0	1	1	1	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	109	0.2400881057268722	liu	1.0	1	Patient183	524	327	280	39	0.122257053	938	0.165677406	1	skin	6.566666667	PD	84	572	84	25	0	Pembrolizumab	3	1	220	0	0	1	1	0	0	0	1	1	skin	NMM	MK3475	0	0	0	0.0	0.0	1	1	skin	3	-197	na	0.51	3.03	SRR10898375	101	40	342	2	1	0	1	0	1	1	0	0	3	20	2	Interactors	0.39215686274509803
32	SRR10801749	0	SRR10801704	liu	Patient86		M	SD	0.0	1327.0	1.0	1327.0		SRR10900571							SRR10801749	melanoma	1.0	2.0	1.0	2.0	1	2.0	2.0	1.0	1.0	liu	0	0	2	0	1	1	0	0	0	0	1	1	0	0	1	1	2	0	1	0	0	0	1	1	0	1	0	0	0	0	2	0	0	1	0	0	0	0	2	1	0	0	0	0	0	2	0	0	1	0	1	1	1	1	0	0	1	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	2	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	2	0	0	1	0	1	1	1	1	0	0	1	1	1	0	0	1	0	2	0	1	0	0	0	0	1	1	0	0	0	1	0	1	1	0	0	1	0	1	0	0	1	1	0	0	2	0	1	0	0	0	1	2	1	0	1	0	0	0	1	0	0	1	1	0	1	0	0	0	0	2	1	0	1	0	0	1	1	0	1	0	2	1	1	1	0	1	0	0	0	1	0	0	1	1	0	0	1	0	0	0	0	1	1	0	0	2	0	0	1	1	0	1	0	1	0	0	0	2	0	1	0	1	1	2	1	107	0.2356828193832599	liu	2.0	0	Patient86	435	279	196	73	0.271375465	576	0.034541373	1	lymph node	1.6	SD	1327	1327	79	48	1	Pembrolizumab	3		144	0	0	1	1	0	1	0	1	0	skin	NM	MK3475	0	0	1	0.0	0.0	0	2	lymph node	3	-48	372	0.14	2.49	SRR10801749	68	43	323	2	0	0	0	0	1	0	1	1	9	9	3	Neither	0.6231884057971014
33	SRR11080191	1	SRR10899811	liu	Patient156		M	PD	1.0	87.0	1.0	80.0		SRR10899967							SRR11080191	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	0	1	0	1	0	1	1	0	0	2	0	0	1	0	1	0	0	0	2	0	1	1	1	2	0	0	1	0	0	1	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	2	1	1	1	0	0	1	1	1	0	0	0	0	1	0	0	1	0	0	0	1	1	0	1	0	1	0	1	0	0	1	0	0	1	0	0	0	1	1	1	2	0	1	2	0	1	0	0	0	1	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1	0	1	1	1	1	0	2	0	0	1	1	0	2	0	0	1	1	1	1	1	1	0	1	1	0	0	1	1	1	1	1	2	0	0	0	2	1	0	0	1	2	1	0	1	0	1	1	0	1	0	0	0	1	0	0	0	1	0	0	0	1	1	1	0	1	0	1	0	0	0	1	0	0	1	0	0	1	0	1	0	0	0	1	1	2	0	1	1	0	0	0	0	1	1	0	0	0	0	0	1	0	0	1	1	0	0	0	1	2	0	0	1	113	0.2488986784140969	liu	1.0	0	Patient156	303	202	160	36	0.183673469	630	0.251593523	1	skin	0.5	PD	80	87	80	4	0	Pembrolizumab	3	0	450	1	1	1	1	1	0	0	1	1	skin	x	pembrolizumab	0	0	0	0.0	0.0	0	0	skin	3	-15	na	0.51	1.97	SRR11080191	34	34	206	3	0	0	0	0	1	0	0	0	7	14	1	HLA	0.9714285714285714
34	SRR10899829	1	SRR10899821	liu	Patient134		M	PD	1.0	590.0	1.0	63.0		SRR10842365							SRR10899829	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	1	0	0	1	0	0	1	2	1	1	1	0	0	2	2	1	2	1	1	1	0	0	0	1	0	0	1	1	0	0	1	1	1	0	0	0	1	0	0	2	2	0	1	0	0	0	0	1	1	2	1	1	0	0	1	0	1	0	0	0	1	0	1	2	1	0	0	1	0	0	1	0	1	1	0	0	0	1	0	1	0	1	1	1	1	0	0	0	0	1	1	1	0	1	1	0	1	0	0	0	0	0	0	1	1	1	0	0	1	0	1	1	0	0	1	0	1	0	1	0	1	0	0	0	0	2	0	1	0	2	1	0	0	1	0	1	0	1	0	0	1	1	0	0	2	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	1	1	0	1	0	2	0	0	0	1	1	1	1	0	0	0	0	0	0	1	0	0	1	0	0	0	2	0	1	0	0	1	0	2	2	0	1	1	1	1	0	0	0	1	1	2	0	0	0	1	1	0	0	1	1	1	0	1	2	0	1	0	123	0.2709251101321586	liu	1.0	1	Patient134	492	328	239	79	0.248427673	1029	0.079132106	1	skin	4.433333333	PD	63	590	63	3	0	Pembrolizumab	2	0	172	0	0	0	0	1	0	0	1	1	skin	nodular	Pembro	0	0	0	1.0	0.0	0	0	skin	3	-133	na	0.38	2.12	SRR10899829	71	45	355	1	0	0	0	0	1	0	2	2	8	5	1	Interactors	0.625
35	SRR10801700	2	SRR10801652	liu	Patient47		F	PD	0.0	937.0	1.0	74.0		SRR10900006							SRR10801700	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	1	2	1	0	0	1	0	0	1	2	0	0	2	0	1	1	0	0	0	0	1	1	2	0	0	0	0	1	0	1	0	0	0	0	1	0	0	2	0	0	1	1	0	0	1	0	0	2	0	0	1	0	1	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	1	0	0	1	1	1	2	0	1	0	0	0	0	1	1	0	0	1	0	1	0	0	1	0	0	1	1	1	1	0	1	0	1	0	1	0	0	1	1	0	1	1	0	1	0	1	0	0	0	0	0	0	1	1	0	0	0	1	0	0	2	0	0	1	1	1	0	0	1	0	1	0	0	1	1	0	2	0	0	2	0	0	0	0	1	0	0	1	0	1	0	1	0	0	0	0	0	1	1	2	0	1	1	1	0	1	1	0	1	1	1	0	0	2	0	1	1	0	1	0	0	0	0	0	0	0	0	0	1	1	0	1	0	1	1	0	0	0	0	0	0	1	0	0	1	2	1	0	0	1	1	0	1	1	0	0	2	0	109	0.2400881057268722	liu	1.0	0	Patient47	1087	756	641	66	0.093352192	2511	0.19079258	0	skin	2.5	PD	74	937	74	6	0	Nivolumab	3	0	340	1	0	1	1	1	0	1	1	0	skin	nodular	Nivolumab	0	0	0	1.0	0.0	0	0	skin	3	-74	na	0.91	3.19	SRR10801700	167	110	758	6	2	2	2	1	1	1	2	2	6	30	5	HLA	0.6547619047619048
36	SRR10898315	0	SRR10898359	liu	Patient20		F	PD	1.0	242.0	1.0	84.0		SRR10900560							SRR10898315	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	1	0	0	0	0	1	1	0	0	0	0	2	2	0	0	0	1	0	0	1	1	1	1	0	0	1	1	0	1	1	1	0	0	0	1	1	0	0	0	0	0	0	0	2	0	0	1	1	0	0	0	2	0	0	0	0	1	0	0	0	2	0	0	0	2	2	0	2	1	0	2	0	2	0	0	0	0	1	0	2	1	1	1	0	2	1	1	0	0	0	1	2	1	0	0	1	1	2	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	1	1	0	0	0	0	0	1	1	0	0	0	1	0	0	1	0	1	1	0	1	0	0	0	1	1	0	1	2	0	1	0	1	1	0	2	1	0	1	0	1	0	0	1	1	0	1	0	0	2	0	1	1	0	0	0	0	0	1	0	0	1	1	0	0	1	0	0	1	0	1	0	1	1	0	0	0	1	1	0	2	0	2	0	2	0	0	0	1	1	0	2	0	1	0	1	0	0	2	0	1	2	2	0	0	0	1	121	0.2665198237885463	liu	1.0	0	Patient20	569	394	315	65	0.171052632	1216	0.13463337	0	skin	0.0	PD	84	242	84	15	0	Nivolumab	3	0	214	0	1	1	1	1	1	1	1	1	skin	NM	Nivolumab	1	0	1	0.0	0.0	0	1	skin	3	0	209	0.45	2.06	SRR10898315	89	54	410	7	1	1	1	1	1	0	1	1	5	8	5	Neither	0.6
37	SRR10899920	0	SRR10899816	liu	Patient146		F	CR	0.0	612.0	0.0	612.0		SRR10900580							SRR10899920	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	1	0	0	0	0	1	1	0	1	1	0	0	2	0	1	1	1	1	2	1	0	1	1	1	1	2	0	0	2	0	0	0	0	0	2	0	2	1	0	0	1	0	0	0	0	1	1	1	1	1	0	0	2	2	0	0	0	1	2	0	0	0	1	0	0	2	0	1	0	1	1	1	1	0	1	0	0	0	0	0	2	1	0	1	1	0	0	2	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	1	0	0	2	0	1	0	0	1	0	1	0	0	0	0	1	2	1	0	0	2	0	0	0	2	2	1	0	0	1	0	0	0	0	1	0	1	0	1	0	1	1	0	2	1	0	0	0	0	0	0	1	0	1	1	0	1	1	1	0	0	0	2	0	0	2	0	1	0	2	0	0	0	1	0	0	0	0	2	1	0	2	0	0	0	0	1	0	1	0	1	0	0	0	0	0	2	0	0	1	0	1	2	0	0	0	1	1	2	1	1	0	0	0	1	123	0.2709251101321586	liu	2.0	1	Patient146	564	375	306	35	0.102639296	1173	0.231218754	0	skin	4.4	CR	612	612	110	26	1	Pembrolizumab	3	0	330	1	0	1	0	1	1	0	0	0	skin	nodular	MK3475	0	0	0	0.0	0.0	0	0	skin	3	-132	na	0.89	1.98	SRR10899920	85	51	388	4	1	0	1	1	1	0	1	1	7	16	1	TFH	0.5930232558139535
38	SRR10899771	2	SRR10899966	liu	Patient13		M	PD	1.0	58.0	1.0	44.0		SRR10842373							SRR10899771	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	1	1	1	0	1	1	0	1	1	0	0	2	0	0	1	0	1	2	1	0	0	1	0	0	0	0	1	0	1	1	0	0	0	0	1	0	2	0	0	1	1	0	0	1	0	0	1	0	2	0	0	1	0	0	1	1	0	0	1	1	0	0	0	0	1	0	0	1	0	1	0	1	1	0	1	2	0	1	0	1	1	0	1	0	0	1	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1	0	2	0	1	0	1	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	1	0	0	0	2	0	0	1	2	2	0	0	0	0	0	1	2	1	2	0	0	0	0	1	2	0	0	0	1	0	0	0	1	0	1	0	0	1	0	0	2	0	0	0	1	2	1	0	1	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	1	0	0	1	1	0	0	1	2	2	2	0	0	0	0	0	0	1	0	1	1	0	1	0	0	0	106	0.2334801762114537	liu	1.0	0	Patient13	913	593	521	53	0.092334495	1733	0.13403875	1	skin	0.9	PD	44	58	44	2	0	Pembrolizumab	3	1	970	1	0	1	0	0	1	0	1	1	skin	x	MK3475	0	0	1	0.0	0.0	0	2	skin	3	-27	203	0.89	2.24	SRR10899771	131	97	629	3	1	0	1	0	1	2	1	1	9	20	6	HLA	0.7348484848484849
39	SRR10899805	0	SRR10899972	liu	Patient141		F	PR	0.0	875.0	0.0	875.0		SRR10842375							SRR10899805	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	1	2	1	0	1	2	0	1	0	0	0	0	1	1	1	1	0	0	0	1	0	1	1	0	1	0	2	0	0	0	0	2	0	0	0	1	0	0	0	0	0	0	0	0	2	0	1	1	0	1	1	1	1	1	0	0	0	0	1	0	0	1	1	0	1	2	1	0	0	1	1	0	1	1	0	0	2	1	1	0	0	1	0	1	1	0	0	0	0	0	1	0	2	0	0	0	2	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	2	0	1	1	1	2	0	1	0	0	0	1	0	1	0	1	2	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	0	1	0	0	1	0	0	1	0	0	2	1	0	1	1	1	0	0	1	0	1	0	0	0	0	1	2	0	2	0	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	1	0	2	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	103	0.2268722466960352	liu	2.0	0	Patient141	86	60	53	2	0.036363636	194	0.130179253	0	skin	3.033333333	PR	875	875	81	52	1	Nivolumab	3	0	242	1	0	1	0	1	0	0	0	0	skin	superficial spreading 	Nivolumab	0	0	0	0.0	0.0	0	0	skin	3	-91	na	0.72	4.49	SRR10899805	20	3	99	1	0	0	0	0	1	0	0	0	2	1	0	Neither	0.14285714285714285
40	SRR10898092	1	SRR10898095	liu	Patient33		F	PR	0.0	1679.0	0.0	1679.0		SRR10899975							SRR10898092	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	2	1	0	1	2	1	0	0	2	1	0	1	1	1	1	2	0	1	1	1	1	1	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	1	0	1	0	1	1	0	2	0	0	2	1	0	0	2	2	0	0	1	1	1	0	0	0	0	0	1	0	0	0	1	1	0	1	1	0	1	0	0	2	0	1	1	1	1	0	2	0	1	0	0	2	0	1	1	0	0	0	0	0	0	0	1	1	0	0	1	1	0	1	0	0	0	0	1	0	0	0	0	1	0	1	0	1	0	0	1	0	0	2	0	1	1	0	1	0	1	1	1	0	1	1	0	0	1	1	0	1	2	1	2	1	1	0	1	0	1	0	1	0	0	1	1	1	0	0	1	0	1	0	1	0	1	1	1	0	1	1	1	0	0	1	1	0	0	0	2	0	0	1	0	0	0	0	0	0	0	1	2	0	0	0	0	0	1	2	0	1	0	0	1	0	0	0	0	0	1	0	0	0	1	1	0	0	1	0	0	1	0	122	0.2687224669603524	liu	2.0	0	Patient33	17	10	7	2	0.222222222	35	0.023681914	0	skin	3.6	PR	1679	1679	79	81	1	Pembrolizumab	3	0	317	0	0	1	1	1	1	0	0	0	skin	NM	MK3475	0	0	1	0.0	0.0	0	1	skin	1	-107	-44	0.17	2.11	SRR10898092	24	8	78	3	1	0	1	0	0	0	0	0	1	10	3	HLA	0.32
41	SRR10801664	2	SRR10801719	liu	Patient96		M	CR	0.0	913.0	0.0	913.0		SRR10900550							SRR10801664	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	1	0	1	0	0	0	0	0	1	1	0	1	0	0	0	1	1	0	1	0	0	2	1	0	1	0	0	1	0	0	1	2	1	1	0	0	0	0	1	0	1	0	1	0	0	1	0	0	0	2	0	0	1	0	0	0	0	1	0	1	0	0	0	0	0	1	1	1	1	0	1	0	0	0	0	0	0	1	0	1	1	0	2	0	1	1	0	0	1	1	0	0	2	1	0	0	0	1	1	1	0	0	0	1	0	1	1	0	1	1	0	0	0	1	1	0	0	1	2	0	1	0	0	0	1	0	0	1	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	2	1	1	0	2	1	0	2	0	0	0	0	2	0	0	1	0	0	1	0	2	0	0	1	0	0	0	0	1	1	0	1	0	0	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	1	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	1	0	0	0	1	0	0	0	96	0.211453744493392	liu	2.0	0	Patient96	959	649	588	50	0.078369906	2136	0.196499246	1	pancreas	2.7	CR	913	913	273	10	0	Nivolumab	3	0	174	0	0	0	0	1	1	0	0	0	skin	unknown	Nivolumab	0	0	0	0.0	0.0	0	0	liver/visceral	3	-81	na	0.82	2.22	SRR10801664	134	100	662	5	2	0	2	1	1	1	2	2	8	23	6	HLA	0.7407407407407407
42	SRR10801671	1	SRR10801644	liu	Patient7		M	SD	1.0	269.0	1.0	217.0		SRR10900597							SRR10801671	melanoma	1.0	2.0	1.0	1.0	2	2.0	1.0	1.0	1.0	liu	1	0	1	2	1	0	1	1	2	0	2	0	0	0	1	1	1	0	1	2	0	0	1	0	0	0	1	2	1	1	0	0	1	1	0	1	1	1	2	0	1	0	0	1	1	0	0	0	0	1	0	1	1	1	0	0	2	0	0	0	0	0	1	0	0	0	1	1	0	0	0	1	1	1	1	0	1	1	1	0	0	1	0	0	0	0	1	1	0	0	1	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	1	2	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	2	0	0	1	0	1	1	0	1	1	0	0	1	1	1	0	0	0	1	0	2	1	1	0	0	0	0	0	1	1	1	2	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	1	0	0	1	1	0	0	1	0	0	0	1	1	1	0	0	1	2	1	0	0	0	1	0	2	1	1	0	1	0	1	0	0	0	0	0	0	0	2	1	0	1	1	1	0	114	0.2511013215859031	liu	2.0	0	Patient7	121	79	47	28	0.373333333	138	0.168904284	1	skin	2.3	SD	217	269	77	7	0	Pembrolizumab	3	0	263	1	0	1	1	1	1	0	1	1	occult	occult melanoma	MK3475	no	0	1	0.0	0.0	0	2	skin	2	-69	54	0.88	2.35	SRR10801671	28	12	117	1	1	2	1	0	1	0	0	0	5	10	0	HLA	0.41379310344827586
43	SRR10898309	0	SRR10898288	liu	Patient18		M	PD	1.0	130.0	1.0	86.0		SRR10900020							SRR10898309	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	1	0	0	1	0	0	1	1	0	1	0	0	0	2	1	0	0	1	1	1	2	0	1	1	0	1	0	0	2	2	0	0	0	2	0	1	2	0	1	0	1	0	0	1	0	0	0	1	1	0	1	1	1	0	0	0	0	0	1	2	0	0	0	1	0	1	1	1	1	0	0	0	0	1	1	1	0	2	1	1	2	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	1	2	0	0	1	0	0	1	0	0	0	0	1	1	2	1	1	2	0	0	0	0	0	1	0	0	1	0	0	2	0	0	1	0	0	0	1	1	2	2	0	1	0	1	1	0	0	0	2	1	0	2	0	1	0	0	2	1	0	1	1	0	1	0	0	0	0	2	0	1	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	2	1	0	1	0	1	0	0	0	0	0	0	1	1	0	0	1	1	0	0	0	0	0	0	0	111	0.2444933920704846	liu	1.0	0	Patient18	526	342	293	42	0.125373134	983	0.147651333	1	skin	16.3	PD	86	130	86	8	0	Nivolumab	0	0	217	0	0	1	0	0	0	0	1	1	skin	SSM	Nivolumab	0	0	0	0.0	0.0	0	0	skin	3	-490	na	0.92	1.9	SRR10898309	70	57	343	2	2	0	2	0	0	1	2	2	4	3	2	Neither	0.8028169014084507
44	SRR10868923	3	SRR10842035	liu	Patient106		F	CR	0.0	780.0	0.0	780.0		SRR10841996							SRR10868923	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	0	1	2	0	0	1	1	0	1	2	0	0	0	1	1	0	2	0	1	0	1	0	1	0	1	1	0	1	1	1	1	0	1	0	0	0	0	0	0	1	1	0	2	0	0	0	0	0	0	0	1	1	2	1	1	1	0	0	0	1	0	0	2	0	0	1	2	0	0	0	0	0	0	0	1	0	0	2	0	1	0	2	1	0	0	0	1	1	0	1	0	1	1	2	0	0	0	1	1	0	0	1	0	1	1	0	0	1	0	0	0	1	2	0	0	0	1	1	1	2	2	2	1	0	0	0	0	2	0	1	0	0	0	0	0	0	0	1	1	1	0	0	0	0	1	1	0	0	0	0	1	0	1	0	0	1	0	1	0	0	0	0	0	1	0	1	0	0	0	2	1	1	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	1	0	1	1	1	0	1	0	0	0	0	1	1	0	0	0	1	0	0	1	0	0	1	0	1	1	0	0	0	0	1	108	0.237885462555066	liu	2.0	0	Patient106	380	245	194	36	0.156521739	726	0.22414699	0	skin	2.5	CR	780	780	311	33	1	Pembrolizumab	3	0	403	1	0	1	0	0	0	0	0	0	skin	SSM	MK3475	0	1	0	0.0	0.0	0	1	skin	3	-74	na	0.62	2.34	SRR10868923	41	35	224	2	0	0	0	0	2	1	1	1	2	10	4	HLA	0.8333333333333334
45	SRR10801691	0	SRR10801640	liu	Patient79		F	PD	0.0	849.0	1.0	84.0		SRR10900573							SRR10801691	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	2	1	0	0	0	1	1	0	2	1	0	0	0	0	1	2	0	0	1	1	0	1	0	2	0	0	2	1	1	1	1	1	0	1	0	0	0	0	1	0	1	1	1	0	1	0	1	0	0	0	2	0	0	0	1	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	1	2	0	1	1	0	2	1	1	0	0	0	0	1	2	0	0	0	0	1	2	0	1	1	0	1	0	0	0	1	2	1	0	1	1	0	1	0	2	1	1	0	0	0	1	0	0	0	0	0	0	2	0	0	0	1	1	0	0	1	0	0	0	0	1	1	0	0	1	0	0	0	1	0	1	0	0	0	1	0	0	0	1	0	1	0	0	1	0	0	0	0	1	1	0	0	0	0	0	1	0	1	0	0	1	1	1	0	1	1	0	0	0	1	0	1	0	0	1	0	1	1	1	0	1	0	0	0	0	0	2	1	1	0	0	0	2	0	1	0	1	1	1	0	0	0	0	0	0	110	0.2422907488986784	liu	1.0	0	Patient79	320	205	149	48	0.243654822	591	0.214096097	0	brain	4.5	PD	84	849	84	35	1	Pembrolizumab	3	0	171	0	0	1	1	1	0	0	1	0	skin	ssm	pembrolizumab	1	1	0	0.0	0.0	0	1	brain	3	-136	na	0.69	1.91	SRR10801691	61	25	189	1	0	0	0	1	1	0	0	0	2	10	2	Neither	0.4032258064516129
46	SRR10801692	0	SRR10801685	liu	Patient63		F	PD	1.0	178.0	1.0	89.0		SRR10899998							SRR10801692	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	2	0	1	0	1	1	1	0	0	1	0	1	1	1	0	0	1	0	0	0	1	1	2	0	1	2	1	2	0	0	1	0	0	1	0	0	0	1	0	1	0	0	0	1	2	0	1	0	0	1	0	1	1	0	0	0	0	1	1	0	1	0	0	1	1	1	0	0	1	0	0	0	0	0	0	1	1	1	0	1	0	0	0	0	1	0	1	1	1	1	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	1	2	1	0	1	0	0	0	0	2	1	1	0	0	0	0	0	0	1	1	1	1	0	0	1	1	0	0	1	0	1	0	0	0	1	1	0	0	1	0	0	0	0	0	1	1	0	2	1	0	0	1	1	0	1	0	0	0	0	1	1	0	0	0	1	1	0	1	0	0	0	1	1	0	1	1	1	0	0	0	0	0	1	1	1	0	1	0	0	2	1	0	2	0	1	0	0	0	0	0	1	0	2	1	0	1	1	1	0	110	0.2422907488986784	liu	1.0	0	Patient63	142	84	46	20	0.303030303	188	0.472099143	0	skin	2.5	PD	89	178	89	12	0	Nivolumab	3	1	259	1	0	1	1	1	1	1	1	1	mucosal	mucosal	Nivolumab	0	0	1	0.0	0.0	0	1	skin	3	-74	425	0.93	2.62	SRR10801692	14	24	125	1	1	0	1	0	0	0	0	0	5	9	3	Neither	1.6
47	SRR10898312	0	SRR10899116	liu	Patient15		F	PR	1.0	149.0	1.0	105.0		SRR10899978							SRR10898312	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	0	1	1	0	0	2	0	0	1	1	1	1	1	0	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	1	1	1	0	1	0	1	0	0	1	1	0	1	0	0	1	0	0	0	1	1	1	0	2	0	0	1	0	1	1	0	0	1	1	0	0	2	0	1	0	0	1	1	1	1	0	0	2	0	1	0	1	1	0	0	0	0	1	0	1	0	0	2	2	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	2	1	2	1	1	0	0	0	1	0	1	1	0	1	1	2	1	1	1	0	1	0	0	1	1	0	0	1	1	1	0	0	2	0	2	0	2	0	0	0	0	2	1	0	1	0	1	0	1	2	0	0	0	1	1	1	0	1	0	0	1	0	1	2	0	1	0	1	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	1	0	1	0	0	1	0	0	0	0	1	0	0	1	0	0	0	0	1	1	0	1	1	0	0	0	0	0	0	116	0.2555066079295154	liu	2.0	1	Patient15	263	182	134	41	0.234285714	530	0.187909079	0	skin	5.0	PR	105	149	84	6	0	Pembrolizumab	3	0	225	0	0	1	1	1	0	1	1	1	skin	LMM	MK 3475	1	1	1	0.0	0.0	0	3	skin	3	-150	108	0.61	2.07	SRR10898312	56	15	202	5	1	0	1	0	1	0	0	0	1	10	0	TFH	0.2631578947368421
48	SRR10801698	0	SRR10801662	liu	Patient73		M	PD	1.0	846.0	1.0	85.0		SRR10899994							SRR10801698	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	0	0	0	0	1	1	2	1	1	0	1	0	2	1	1	1	1	0	1	0	0	1	0	1	0	0	1	0	1	1	1	0	0	1	0	0	1	0	0	1	0	0	1	0	1	0	0	1	1	0	0	1	1	0	0	0	0	2	0	0	0	1	0	0	0	2	0	0	1	1	0	0	1	1	0	1	1	1	2	0	2	1	1	1	0	1	0	0	0	0	1	2	2	0	0	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	1	1	0	1	1	0	0	0	0	0	1	0	1	1	1	0	2	0	1	0	1	1	0	1	0	1	1	0	2	1	1	1	0	2	0	1	0	0	0	1	0	0	2	1	1	0	1	0	1	0	0	0	1	1	1	1	0	0	0	0	1	1	1	0	0	1	0	1	1	0	1	0	0	0	1	1	1	0	0	0	0	0	0	0	0	1	1	0	1	0	0	2	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	116	0.2555066079295154	liu	1.0	1	Patient73	127	90	69	17	0.197674419	262	0.232352565	1	skin	1.9	PD	85	846	85	22	0	Nivolumab	3	1	279	1	0	1	1	0	0	0	1	1	skin	x	nivolumab	0	0	1	0.0	0.0	1	2	skin	3	-56	139	0.77	3.33	SRR10801698	16	13	108	0	0	0	0	0	0	0	0	0	4	5	1	TFH	0.7647058823529411
49	SRR10898325	3	SRR10899117	liu	Patient205		F	PD	1.0	392.0	1.0	190.0		SRR10900013							SRR10898325	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	0	0	1	1	1	0	1	0	1	1	0	0	0	2	0	0	1	0	0	2	0	0	1	0	0	2	0	0	1	1	0	0	0	2	0	1	1	0	0	1	0	0	0	1	0	0	1	2	0	1	2	1	0	0	0	2	0	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	2	0	1	1	0	1	1	0	0	0	0	0	0	0	0	1	0	1	0	0	1	1	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	2	1	1	0	1	1	1	0	0	0	0	1	0	0	0	0	1	1	0	0	1	0	1	1	0	1	0	0	0	0	1	2	1	0	1	0	0	1	1	1	0	0	0	0	1	0	0	1	0	0	1	0	1	2	0	0	1	0	1	0	1	0	1	1	0	0	1	1	1	2	0	1	0	0	0	0	1	0	0	1	1	0	1	1	1	0	0	1	1	0	0	0	0	0	2	0	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	101	0.2224669603524229	liu	1.0	0	Patient205	853	572	466	60	0.114068441	1702	0.132058145	0	skin	1.2	PD	190	392	190	10	0	Pembrolizumab	3	0	215	1	0	0	1	1	1	1	1	1	skin	spindle-shaped	MK3475	0	0	0	0.0	0.0	0	0	skin	3	-36	na	0.8	1.99	SRR10898325	127	75	573	2	0	0	0	0	1	2	1	1	6	14	5	HLA	0.5859375
50	SRR10801680	2	SRR10801655	liu	Patient94		F	PD	1.0	40.0	1.0	40.0		SRR10900586							SRR10801680	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	1	0	0	0	1	1	0	1	0	0	0	2	1	0	1	0	0	0	0	0	1	0	1	0	1	0	1	0	0	1	1	0	1	2	0	0	0	0	0	0	0	0	0	1	1	0	0	1	1	0	0	1	1	0	0	0	0	2	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	1	1	1	1	0	1	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	1	0	0	1	0	1	0	1	0	0	0	0	0	1	0	0	1	0	1	1	1	1	1	0	0	0	0	1	1	0	0	2	2	1	0	1	1	1	0	0	0	1	1	0	1	0	1	0	0	1	0	1	1	0	0	0	0	2	1	1	1	1	1	1	0	1	1	1	1	0	0	2	0	1	1	0	1	0	0	0	1	1	0	0	0	0	0	0	1	1	0	1	1	0	0	1	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	96	0.211453744493392	liu	1.0	0	Patient94	414	268	227	21	0.084677419	929	0.902095292	0	skin	1.0	PD	40	40	40	1	0	Pembrolizumab	3	2	817	1	1	1	1	1	1	1	1	1	skin	nodular	MK3475	1	1	1	0.0	0.0	0	2	skin	3	-31	140	0.85	1.13	SRR10801680	58	45	270	2	1	0	1	0	1	0	0	0	2	5	3	HLA	0.7627118644067796
51	SRR10801686	0	SRR10801660	liu	Patient83		M	PD	1.0	71.0	1.0	71.0		SRR10899984							SRR10801686	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	0	0	1	0	0	0	0	0	0	0	1	0	1	0	1	1	0	0	0	0	1	0	0	1	1	1	1	0	1	1	1	0	0	0	0	0	1	2	0	0	0	0	0	0	1	0	1	0	2	0	0	1	1	0	0	1	0	0	0	0	1	1	0	0	1	2	1	0	1	0	1	1	1	1	1	0	0	1	1	0	1	1	2	1	0	1	0	2	0	0	0	0	2	1	0	0	0	1	0	0	0	1	0	0	1	2	0	0	0	0	0	0	0	2	0	1	1	1	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	1	1	1	1	1	1	0	1	2	1	0	1	0	0	1	1	0	1	1	0	0	0	1	0	1	1	1	1	0	0	0	1	0	1	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	1	0	1	1	0	0	1	0	0	1	0	0	1	0	0	0	0	0	1	0	1	0	1	1	0	1	0	102	0.224669603524229	liu	1.0	0	Patient83	309	194	149	39	0.207446809	539	0.135187708	1	skin	8.1	PD	71	71	71	3	0	Nivolumab	3	1	496	1	0	0	1	1	0	0	1	1	skin	SSM	Nivolumab	0	0	1	0.0	0.0	0	1	skin	1	-243	-147	0.94	2.01	SRR10801686	45	27	202	2	0	1	0	1	1	0	0	0	3	15	1	Neither	0.5869565217391305
52	SRR10899802	1	SRR10899791	liu	Patient145		M	CR	0.0	833.0	0.0	833.0		SRR10899986							SRR10899802	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	0	1	1	0	0	1	0	0	1	0	0	0	1	0	1	1	1	0	0	1	0	1	1	1	0	0	0	1	0	0	1	1	1	1	1	0	1	0	1	1	1	0	0	0	0	1	0	0	1	1	0	1	0	1	0	0	0	0	1	1	0	0	1	1	0	0	0	0	0	0	0	0	2	0	2	0	1	1	0	1	2	0	1	1	1	1	1	1	0	0	0	0	1	0	2	0	0	0	1	0	0	0	0	0	0	2	0	1	1	1	0	1	0	0	1	0	1	1	1	1	0	1	0	0	0	0	0	0	1	1	1	1	1	0	0	1	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	1	2	1	0	2	1	0	0	0	1	1	0	2	0	0	0	0	1	0	0	1	1	1	0	0	0	1	0	0	0	1	1	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	1	1	1	1	1	0	2	0	0	0	1	1	0	0	0	0	2	1	0	0	0	1	0	1	0	1	0	0	0	107	0.2356828193832599	liu	2.0	0	Patient145	433	288	264	13	0.046931408	1033	0.224408315	1	skin	6.133333333	CR	833	833	77	25	0	Pembrolizumab	3	0	308	1	0	1	1	1	1	1	0	0	skin	nodular	MK3475	0	0	0	0.0	0.0	0	0	skin	3	-184	na	0.67	3.31	SRR10899802	65	40	306	0	0	0	0	0	1	0	0	0	5	3	2	HLA	0.6060606060606061
53	SRR10898348	2	SRR10899119	liu	Patient188		M	PD	1.0	74.0	1.0	23.0		SRR10899976							SRR10898348	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	0	1	0	1	0	0	0	1	0	1	1	0	0	2	0	0	0	1	1	0	2	1	0	0	0	0	2	0	0	2	2	0	1	0	0	0	1	1	1	0	0	0	0	0	0	0	0	1	2	0	1	0	1	1	0	0	1	0	1	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	2	0	1	2	2	0	0	1	0	0	0	0	1	1	1	0	0	0	1	1	0	0	0	0	0	0	1	2	0	1	0	0	0	0	0	0	0	2	1	1	1	1	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	2	2	0	0	2	0	1	0	0	0	1	1	1	2	0	0	0	0	2	1	1	1	0	0	1	0	2	0	1	1	0	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	2	0	1	1	1	0	0	0	0	1	1	2	0	1	0	0	0	0	1	0	1	2	1	0	0	0	0	103	0.2268722466960352	liu	1.0	0	Patient188	41	22	16	6	0.272727273	54	0.251935266	1	skin	1.166666667	PD	23	74	23	1	0	Pembrolizumab	1	1	184	0	0	0	0	1	0	0	1	1	acral	ALM	Pembro	0	0	0	0.0	0.0	0	1	skin	3	-35	na	0.91	2.13	SRR10898348	4	3	26	1	0	0	0	0	1	0	0	0	0	0	1	HLA	0.6
54	SRR10801668	2	SRR10801696	liu	Patient8		M	SD	1.0	1005.0	1.0	955.0		SRR10900594							SRR10801668	melanoma	1.0	2.0	1.0	2.0	1	2.0	2.0	1.0	1.0	liu	0	1	0	2	0	1	1	1	1	1	1	0	0	0	0	1	2	0	0	0	1	0	1	0	0	1	0	2	0	0	0	0	0	1	0	0	0	1	1	0	1	0	1	0	0	2	0	0	2	1	1	2	1	1	1	1	0	1	0	0	0	0	2	0	1	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	1	0	1	1	0	0	2	1	0	0	0	0	1	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	2	1	0	0	0	1	0	1	0	0	0	0	0	1	0	0	2	0	0	0	1	0	0	2	1	0	1	1	0	0	2	2	1	0	1	1	1	1	0	1	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	2	0	2	0	0	1	0	0	0	0	0	0	0	0	1	0	2	0	0	1	2	0	0	0	0	0	0	1	0	0	1	0	2	0	0	2	0	0	0	1	0	1	0	1	0	103	0.2268722466960352	liu	2.0	0	Patient8	311	194	152	40	0.208333333	638	0.273852935	1	skin	3.9	SD	955	1005	72	4	0	Pembrolizumab	2	0	245	0	0	1	0	1	0	0	1	1	skin	NMM	MK3475	yes, 140 mg Decortin H (Colitis)	0	0	0.0	0.0	0	0	skin	3	-116	na	0.72	2.01	SRR10801668	84	19	221	3	1	1	1	0	1	0	0	0	2	4	2	HLA	0.2235294117647059
55	SRR10868924	2	SRR10842008	liu	Patient108		M	PD	1.0	165.0	1.0	77.0		SRR10842068							SRR10868924	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	2	2	0	0	0	1	0	1	0	0	0	0	1	1	0	0	0	1	1	0	0	0	0	1	0	0	1	1	0	1	1	1	0	1	0	1	1	1	2	1	1	0	0	0	1	1	0	0	0	0	0	1	1	2	1	0	0	1	2	0	1	2	0	0	0	1	1	1	0	0	0	1	1	1	0	0	0	0	1	1	0	0	1	0	0	1	2	0	1	1	1	2	1	0	0	0	1	0	1	0	0	0	0	0	1	0	1	0	0	0	2	0	0	1	1	1	1	0	2	1	1	1	0	0	0	0	1	1	2	0	0	1	1	0	0	1	1	1	0	1	1	1	1	0	1	1	0	0	1	1	0	2	2	0	2	0	0	0	0	0	1	0	0	1	1	2	0	0	0	1	1	0	0	1	0	0	1	0	0	0	1	0	0	1	0	0	0	1	0	0	0	1	1	1	0	1	0	0	1	1	0	1	1	0	0	0	2	2	2	2	0	0	1	1	0	0	0	2	0	1	1	0	1	0	0	0	128	0.2819383259911894	liu	1.0	0	Patient108	69	45	31	14	0.311111111	189	0.125993376	1	lymph node	0.6	PD	77	165	77	4	0	Pembrolizumab	3	0	246	1	0	0	1	0	0	0	1	1	acral	unkown	MK3475	0	0	0	0.0	0.0	1	0	lymph node	3	-17	na	0.89	4.12	SRR10868924	11	3	58	2	0	0	0	0	1	0	0	0	3	2	2	HLA	0.25
56	SRR10898346	0	SRR10898352	liu	Patient170		M	SD	0.0	347.0	0.0	347.0		SRR10900549							SRR10898346	melanoma	1.0	2.0	1.0	1.0	2	2.0	1.0	1.0	1.0	liu	0	2	2	0	0	1	1	1	0	0	1	1	0	1	0	2	1	1	2	0	0	1	1	1	2	0	0	2	1	0	1	1	0	0	0	2	1	0	1	0	0	0	0	0	0	1	0	0	1	1	0	0	2	0	0	0	1	0	0	1	0	0	1	0	1	1	2	0	0	0	0	1	2	1	1	0	0	0	0	0	0	2	1	1	1	0	0	1	0	1	0	0	1	2	1	0	0	1	2	1	0	1	0	1	0	0	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	1	0	0	1	1	1	1	1	2	0	0	1	1	1	0	0	1	2	0	0	1	1	1	0	0	1	0	2	0	1	1	0	1	1	1	2	0	2	1	1	1	0	1	1	0	0	1	0	1	0	1	0	1	0	0	0	1	0	2	0	1	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	1	0	0	0	1	1	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	123	0.2709251101321586	liu	2.0	1	Patient170	85	56	48	8	0.142857143	148	0.116162455	1	skin	2.2	SD	347	347	158	14	1	Pembrolizumab	0	0	181	0	0	1	0	0	0	0	0	0	skin	ALM	MK3475	no	0	0	0.0	0.0	0	0	skin	3	-67	na	0.78	3.12	SRR10898346	12	13	74	0	1	0	1	0	0	0	0	0	0	0	0	TFH	1.0
57	SRR10898088	0	SRR10898069	liu	Patient37		M	PD	1.0	275.0	1.0	77.0		SRR10900557							SRR10898088	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	0	1	2	0	0	1	0	1	2	0	0	0	0	0	0	1	1	1	0	1	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1	0	1	0	2	0	0	2	1	0	1	1	0	0	0	2	1	0	0	1	0	0	0	0	2	1	0	1	0	1	1	0	0	2	0	2	0	0	0	0	1	1	2	1	0	1	2	0	1	0	0	1	1	1	2	0	0	0	0	1	0	1	0	0	0	0	0	2	1	0	1	0	0	0	1	1	1	0	2	0	1	1	0	1	0	0	0	0	0	1	0	2	0	0	1	1	0	0	1	1	1	1	0	0	1	1	0	2	1	1	2	0	2	0	0	1	0	0	0	1	1	0	0	0	0	1	0	2	2	1	0	0	1	0	0	0	1	0	1	2	0	0	0	0	0	0	1	0	0	0	0	1	0	0	1	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	1	1	0	1	1	0	2	1	0	1	1	0	1	0	0	1	0	1	0	118	0.2599118942731278	liu	1.0	1	Patient37	48	40	27	12	0.307692308	60	0.074993396	1	lymph node	1.2	PD	77	275	77	7	0	Nivolumab	3	0	335	1	0	1	1	1	1	1	1	1	mucosal	unknown	Nivolumab	0	0	0	0.0	0.0	0	0	lymph node	3	-35	na	0.3	2.09	SRR10898088	9	3	46	0	0	2	0	1	0	0	0	0	0	1	1	TFH	0.3
58	SRR11080226	0	SRR10899820	liu	Patient149		M	SD	1.0	497.0	1.0	210.0		SRR10899973							SRR11080226	melanoma	1.0	2.0	1.0	2.0	1	2.0	2.0	1.0	1.0	liu	1	0	0	1	1	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	2	1	0	1	1	0	1	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	1	1	0	1	1	0	0	0	0	0	1	0	0	1	1	0	0	1	1	0	0	1	0	0	1	2	0	0	0	1	1	0	0	1	2	0	1	0	0	2	1	1	2	0	0	1	1	0	0	0	0	0	0	0	0	2	1	1	0	0	1	0	0	0	1	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	2	0	0	2	1	0	0	2	2	0	0	0	1	1	1	1	0	1	0	0	0	1	0	0	1	0	0	1	0	0	1	2	1	0	0	1	0	1	1	0	1	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	1	0	1	0	2	1	0	1	0	1	0	1	1	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	2	0	98	0.2158590308370044	liu	2.0	0	Patient149	331	219	188	26	0.121495327	690	0.115692174	1	lung	0.366666667	SD	210	497	105	10	0	Pembrolizumab	3	1	218	0	0	0	1	1	1	1	1	1	skin	NMM	Pembrolizumab	0	0	0	1.0	0.0	0	0	lung	3	-11	na	0.44	2.02	SRR11080226	53	30	242	1	1	0	1	0	1	1	0	0	3	16	2	Neither	0.5555555555555556
59	SRR10868925	1	SRR10842034	liu	Patient105		F	MR	1.0	521.0	0.0	378.0		SRR10842347							SRR10868925	melanoma	1.0	2.0	1.0	1.0	1	1.0	1.0	1.0	1.0	liu	1	0	1	1	0	1	1	1	1	0	1	0	1	0	0	2	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	2	0	1	2	1	2	0	0	1	0	0	1	2	1	0	0	0	1	0	1	1	2	1	0	0	0	0	1	0	1	0	0	1	1	0	0	2	0	0	0	1	1	0	0	0	1	1	1	2	0	0	0	0	2	0	0	0	1	0	1	1	0	0	1	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	1	0	0	0	0	1	0	1	0	0	0	1	2	1	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	1	0	0	0	2	0	1	0	1	1	1	1	0	0	1	1	0	0	1	0	1	0	0	1	0	2	1	0	1	0	1	1	0	1	0	1	0	1	0	0	0	2	0	1	0	0	1	0	0	0	0	2	0	1	0	0	0	0	0	0	0	1	0	0	0	0	2	0	101	0.2224669603524229	liu	2.0	0	Patient105	185	125	85	23	0.212962963	334	0.394305859	0	skin	0.7	MR	378	521	82	18	0	Pembrolizumab	3	0	301	1	1	0	1	0	1	0	0	1	skin	unknown	MK3475	1	0	0	0.0	0.0	1	0	skin	3	-22	na	0.86	2.42	SRR10868925	28	28	123	0	0	0	0	0	1	0	0	0	1	2	1	HLA	0.9655172413793104
60	SRR10899970	3	SRR10899961	liu	Patient121		F	PR	0.0	1306.0	1.0	1228.0		SRR10842364							SRR10899970	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	1	1	1	1	0	0	0	0	0	1	1	0	0	0	2	0	2	0	1	1	1	0	1	0	1	1	0	1	0	0	1	0	1	1	0	0	1	2	1	0	1	0	1	0	2	1	0	0	0	1	0	0	2	2	0	0	0	0	0	1	0	0	2	1	1	0	0	1	0	0	1	1	0	1	1	1	0	1	0	0	1	1	0	1	1	0	1	1	0	0	0	1	1	0	0	0	0	1	1	0	0	0	0	0	0	1	1	0	2	1	0	0	0	1	1	0	1	1	0	1	0	2	0	0	0	0	0	0	0	2	0	0	1	0	1	0	2	1	0	1	2	1	1	1	1	2	1	1	1	1	1	1	1	1	0	1	1	0	0	1	0	1	1	1	2	0	0	0	0	0	1	1	1	0	0	0	0	1	1	2	0	1	1	0	1	1	0	1	1	0	0	0	0	1	0	0	1	0	0	0	1	0	0	1	0	0	0	1	1	0	1	1	0	1	2	0	0	0	0	0	0	2	0	2	0	1	0	129	0.2841409691629956	liu	2.0	0	Patient121	1128	767	588	128	0.17877095	2257	0.085643565	0	skin	1.6	PR	1228	1306	77	16	0	Pembrolizumab	3	1	225	0	0	1	1	1	1	0	1	0	skin	x	MK3475	1	0	1	0.0	0.0	0	1	skin	3	-49	33	0.4	2.01	SRR10899970	187	113	748	1	1	2	1	0	0	0	0	0	7	16	6	HLA	0.601063829787234
61	SRR10898321	1	SRR10898894	liu	Patient17		M	SD	1.0	686.0	1.0	202.0		SRR10899992							SRR10898321	melanoma	1.0	2.0	1.0	2.0	1	2.0	2.0	1.0	1.0	liu	2	0	0	0	1	1	0	0	0	0	1	1	0	1	1	0	0	0	0	0	0	1	1	0	0	1	1	0	0	1	0	0	1	2	0	0	1	1	2	0	1	0	0	0	0	1	0	0	1	1	0	0	1	1	0	0	1	0	0	0	0	0	0	1	0	0	0	1	1	0	1	0	2	0	1	0	0	0	0	0	0	1	1	1	0	0	0	1	1	0	0	1	1	0	1	0	0	2	0	1	0	1	1	0	0	0	0	1	0	0	0	0	1	0	2	1	0	0	1	0	0	1	0	0	1	1	1	0	2	1	0	0	1	0	0	0	0	2	1	0	1	0	0	0	0	0	1	0	2	0	1	0	1	1	1	1	1	0	1	0	1	0	0	1	2	0	0	0	0	1	1	0	1	0	1	0	0	2	1	0	0	1	1	0	0	0	0	0	0	0	0	0	1	1	1	0	1	1	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	0	0	1	0	1	2	1	0	0	0	1	0	103	0.2268722466960352	liu	2.0	0	Patient17	550	365	305	52	0.145658263	821	0.059114148	1	lymph node	5.2	SD	202	686	110	21	0	Nivolumab	3	0	192	0	0	0	1	1	1	1	1	1	skin	NM	Nivolumab	0	0	1	0.0	1.0	Reexposure PD-1	1	lymph node	3	-156	280	0.38	2.91	SRR10898321	90	52	389	3	2	0	2	1	1	1	0	0	4	16	2	HLA	0.5714285714285714
62	SRR10899817	1	SRR10899840	liu	Patient143		M	PD	0.0	630.0	1.0	153.0		SRR10900559							SRR10899817	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	0	1	0	0	2	0	1	0	1	0	0	0	1	1	0	2	1	0	0	1	1	0	0	1	1	0	0	1	1	1	1	0	0	0	0	1	1	0	0	0	0	0	0	1	1	0	0	2	0	1	1	2	0	0	0	0	0	0	0	0	1	1	0	2	1	1	0	0	1	1	0	1	0	0	1	2	1	1	0	1	1	0	0	0	0	0	0	1	0	2	1	1	1	0	0	1	0	1	0	0	1	1	0	1	0	0	0	0	0	0	0	0	1	0	1	0	1	0	1	1	0	0	0	0	0	1	0	1	0	0	0	1	1	0	0	0	1	1	1	0	2	2	0	0	0	2	1	0	1	0	1	1	0	1	0	0	0	0	1	0	0	0	1	1	1	0	0	0	1	1	0	1	0	0	1	2	0	2	0	0	0	0	1	1	2	0	0	1	1	1	0	0	1	0	0	0	1	1	1	0	0	1	0	2	2	0	0	1	0	0	1	0	1	0	0	1	0	1	1	1	0	0	0	1	0	116	0.2555066079295154	liu	1.0	2	Patient143	506	334	294	32	0.098159509	1163	0.206019013	1	skin	1.333333333	PD	153	630	79	8	0	Pembrolizumab	0	0	236	1	0	1	1	0	0	0	1	0	skin	superficial spreading 	MK3475	0	0	0	0.0	0.0	0	0	skin	3	-40	na	0.5	3.19	SRR10899817	77	41	361	3	2	0	2	1	1	3	1	1	6	11	4	Interactors	0.5256410256410257
63	SRR10898326	0	SRR10898329	liu	Patient165		M	PD	0.0	75.0	1.0	13.0		SRR10900569							SRR10898326	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	1	1	0	1	0	0	0	0	0	1	0	0	0	1	0	1	0	0	1	0	1	0	0	0	0	0	1	0	0	0	0	2	0	0	0	2	1	0	0	1	0	0	0	0	1	0	2	1	1	1	1	1	2	0	0	1	1	0	1	0	0	0	1	2	0	1	0	1	0	0	0	2	0	2	0	0	2	0	0	0	1	0	0	0	0	0	2	0	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	2	1	1	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	2	0	1	2	0	2	0	0	0	0	0	0	0	2	0	0	0	0	1	1	1	0	1	2	0	0	0	0	0	0	0	2	0	1	0	0	1	1	1	0	0	1	1	0	0	2	0	0	0	2	2	0	1	0	0	0	1	0	2	0	0	2	0	1	0	0	1	0	2	0	0	1	0	1	0	0	2	0	1	0	0	0	0	1	0	0	0	1	1	1	0	0	0	0	1	105	0.2312775330396475	liu	1.0	0	Patient165	963	641	560	60	0.096774194	2015	0.324660445	1	soft tissue	1.133333333	PD	13	75	13	2	0	Pembrolizumab	3	0	335	1	0	1	1	0	0	0	1	0	skin	NM	MK3475	0	0	0	0.0	0.0	1	0	soft tissue	3	-34	na	0.8	1.79	SRR10898326	181	87	657	7	2	0	2	0	0	1	2	2	15	29	4	Neither	0.47802197802197804
64	SRR10898313	2	SRR10898322	liu	Patient172		M	SD	0.0	272.0	1.0	272.0		SRR10899987							SRR10898313	melanoma	1.0	2.0	1.0	1.0	2	2.0	1.0	1.0	1.0	liu	0	2	1	1	0	1	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	1	0	1	0	0	0	0	1	0	0	1	0	0	2	0	1	0	0	0	1	1	0	0	1	0	1	0	0	0	1	0	0	0	1	0	0	1	0	1	0	1	0	1	0	0	1	0	0	0	0	0	1	1	1	1	1	0	0	0	0	1	0	0	1	1	1	0	0	0	1	0	1	0	1	0	0	1	0	0	0	0	0	0	0	1	1	1	0	0	1	1	1	0	1	0	1	0	0	1	1	1	1	0	0	1	1	0	0	1	2	2	0	0	0	2	2	0	0	2	1	1	0	1	1	1	0	0	0	2	0	0	0	1	0	1	1	0	1	0	0	0	2	0	1	0	0	1	0	0	2	0	1	0	1	1	0	0	0	1	0	0	0	1	0	0	1	0	0	1	1	1	1	1	0	0	1	0	0	1	1	1	0	2	1	0	0	1	0	0	0	0	1	0	0	0	0	0	1	0	104	0.2290748898678414	liu	2.0	0	Patient172	1014	678	528	113	0.176287051	2400	0.061750916	1	skin	4.9	SD	272	272	81	12	0	Pembrolizumab	0	0	189	0	0	1	0	0	0	0	1	0	skin	NMM	MK3475	no	0	0	0.0	0.0	0	0	skin	3	-148	na	0.23	2.2	SRR10898313	179	102	754	4	0	1	0	1	1	0	1	1	7	24	4	HLA	0.5666666666666667
65	SRR10898290	0	SRR10898365	liu	Patient173		F	PD	1.0	42.0	1.0	16.0		SRR10900015							SRR10898290	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	1	0	2	0	0	2	1	0	1	0	1	1	0	1	0	2	0	0	0	1	0	0	1	0	0	0	0	0	1	1	0	0	0	2	0	1	0	1	0	0	0	0	0	0	0	1	0	1	1	2	0	1	1	1	0	0	0	0	0	0	0	0	2	0	0	1	1	1	0	0	1	0	2	0	1	0	0	1	1	1	0	1	0	0	0	1	0	0	1	0	0	0	2	1	1	1	1	1	1	2	0	0	0	0	1	0	0	0	2	0	1	0	0	0	1	0	0	1	1	1	1	2	0	0	1	0	0	0	0	1	0	0	1	0	0	0	0	1	1	1	1	0	0	0	0	1	1	0	1	0	2	0	1	0	0	0	0	0	0	0	0	1	0	1	1	2	1	0	0	1	0	0	0	0	1	0	0	1	0	0	1	0	1	0	1	0	0	0	0	1	1	0	1	1	0	0	0	1	0	0	1	0	0	1	1	0	0	1	1	0	0	0	1	0	1	0	0	0	0	0	1	0	0	2	0	1	0	105	0.2312775330396475	liu	1.0	0	Patient173	104	72	58	9	0.134328358	212	0.168239373	0	lung	0.4	PD	16	42	16	1	0	Pembrolizumab	3	0	236	0	0	0	0	1	1	0	1	1	skin	ALM	MK3475	no	0	0	0.0	0.0	0	0	lung	3	-12	na	0.8	3.32	SRR10898290	13	10	77	1	0	1	0	0	1	0	0	0	3	2	0	Neither	0.7142857142857143
66	SRR10898072	1	SRR10898040	liu	Patient36		M	PD	1.0	451.0	1.0	63.0		SRR10900003							SRR10898072	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	1	1	1	0	1	1	1	0	1	0	1	0	0	0	0	1	1	1	0	0	0	0	0	0	2	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	2	0	0	0	0	1	1	0	0	0	0	0	2	1	0	1	0	0	1	1	1	1	0	0	1	0	1	1	1	1	0	1	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	1	0	1	2	1	0	0	0	1	1	0	0	0	1	0	1	0	0	0	2	2	0	0	0	2	1	0	0	2	0	1	0	0	0	1	0	0	1	1	0	0	1	1	2	2	1	0	1	0	0	1	0	1	2	0	1	0	0	0	0	0	0	1	0	1	0	2	1	0	1	0	0	1	0	2	0	0	0	0	1	1	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	97	0.2136563876651982	liu	1.0	1	Patient36	277	180	157	20	0.11299435	543	0.18582013	1	lung	2.7	PD	63	451	63	5	0	Nivolumab	3	1	282	1	0	0	0	1	0	0	1	1	skin	nodular	Nivolumab	0	0	0	1.0	0.0	0	0	lung	3	-81	na	0.84	2.0	SRR10898072	41	16	170	0	1	0	1	0	1	0	0	0	1	3	0	Interactors	0.38095238095238093
67	SRR10898875	1	SRR10898958	liu	Patient169		M	PR	0.0	543.0	0.0	543.0		SRR10900572							SRR10898875	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	1	1	0	0	1	1	0	2	0	1	0	0	1	1	0	0	1	1	1	0	1	1	1	1	0	0	1	1	0	1	1	0	0	0	0	1	0	1	0	1	0	0	1	1	1	0	0	1	1	0	0	1	1	0	0	0	0	0	1	1	1	1	0	1	0	0	0	0	0	0	0	0	0	1	0	2	0	0	1	0	0	1	0	0	0	2	0	0	1	0	0	2	0	1	2	2	0	1	1	0	0	0	0	0	0	1	0	0	0	1	1	0	1	0	0	2	1	1	0	1	1	0	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	2	1	0	1	1	1	0	0	1	1	2	1	2	1	1	1	0	1	1	0	0	1	1	1	1	0	0	0	1	0	0	0	0	1	0	0	1	0	0	0	0	1	0	0	1	0	1	1	0	1	0	0	0	0	2	0	0	0	0	0	0	0	0	1	1	1	0	0	1	0	1	0	1	1	0	0	2	0	0	1	0	1	0	0	0	0	0	1	0	109	0.2400881057268722	liu	2.0	1	Patient169	2100	1382	1113	235	0.174332344	4545	0.196949537	1	skin	4.1	PR	543	543	189	22	0	Pembrolizumab	3	0	372	1	0	1	1	0	0	0	0	0	skin	NMM	MK3475	no	0	0	0.0	0.0	0	0	skin	3	-123	na	0.59	1.96	SRR10898875	261	217	1446	4	0	2	0	1	1	0	1	1	18	39	12	Interactors	0.8282442748091603
68	SRR10801720	2	SRR10801681	liu	Patient99		M	PR	0.0	921.0	1.0	319.0		SRR10900566							SRR10801720	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	0	2	0	0	0	1	1	1	1	1	0	0	0	2	0	1	1	1	0	0	1	0	1	1	2	0	1	0	0	1	0	0	0	0	0	0	0	1	0	2	0	1	1	0	1	0	0	1	1	0	0	1	1	0	0	0	1	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	1	2	1	0	0	0	0	0	0	1	1	0	0	0	1	1	1	1	1	0	1	0	0	0	0	1	0	0	2	1	0	1	0	1	0	0	0	0	0	1	0	1	0	1	0	0	0	1	2	0	0	0	0	0	0	1	0	1	1	2	0	0	2	0	0	1	0	1	1	0	0	0	1	0	0	1	0	0	0	1	1	0	0	2	0	0	1	0	1	0	0	2	1	2	2	0	2	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	1	0	1	0	1	1	2	0	97	0.2136563876651982	liu	2.0	1	Patient99	1392	909	690	190	0.215909091	2796	0.187194201	1	soft tissue	5.2	PR	319	921	158	12	0	Nivolumab	3	0	355	1	0	0	1	1	1	0	1	0	skin	unknown	Nivolumab	1	0	0	0.0	0.0	1	0	soft tissue	3	-155	na	0.34	2.83	SRR10801720	200	126	898	1	0	1	0	0	1	1	1	1	13	19	4	Interactors	0.6268656716417911
69	SRR10801718	0	SRR10801690	liu	Patient44		M	PR	0.0	922.0	0.0	922.0		SRR10900579							SRR10801718	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	1	0	1	1	0	1	1	0	1	0	0	1	0	0	1	1	0	0	0	0	0	1	0	0	0	1	1	1	0	1	1	1	0	1	0	1	0	0	1	1	1	0	0	0	1	0	0	0	0	1	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	1	0	0	2	1	1	1	0	0	0	1	0	1	1	0	1	1	1	1	0	0	0	0	1	0	0	1	0	0	1	0	0	1	1	0	1	0	0	0	0	1	1	2	1	1	1	0	0	1	1	0	1	0	1	0	0	0	2	0	0	0	1	1	0	1	1	1	1	0	1	2	1	1	0	1	0	1	0	0	1	0	2	0	1	1	0	0	2	0	1	1	0	0	1	1	1	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	1	2	0	1	2	1	0	1	1	1	0	0	2	0	0	1	0	0	0	1	0	1	1	0	1	1	0	1	110	0.2422907488986784	liu	2.0	0	Patient44	91	64	44	19	0.301587302	101	0.457883791	1	soft tissue	0.5	PR	922	922	89	52	1	Nivolumab	3	0	326	1	0	0	1	1	1	0	0	0	mucosal	unknown	Nivolumab	0	0	1	0.0	0.0	0	1	soft tissue	3	-15	108	0.32	1.73	SRR10801718	14	14	97	3	1	0	1	0	0	0	0	0	1	15	1	Neither	0.9333333333333333
70	SRR10899826	0	SRR10899803	liu	Patient137		F	CR	0.0	772.0	0.0	772.0		SRR10842366							SRR10899826	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	0	0	1	0	0	1	2	0	0	1	1	0	0	0	0	1	1	0	1	0	0	1	0	1	1	0	0	1	0	0	1	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	1	0	1	2	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	1	1	1	0	0	0	0	0	1	1	1	1	1	2	0	0	1	1	0	0	1	0	0	0	0	1	1	0	0	0	0	1	0	0	1	1	0	1	1	0	1	1	1	0	0	0	0	0	2	1	2	0	1	1	0	0	1	1	2	1	0	0	0	0	0	0	1	1	0	1	0	0	0	1	0	0	1	2	0	0	1	0	0	0	2	0	1	0	0	0	0	1	1	0	0	1	0	0	0	0	1	1	0	0	0	0	1	0	0	1	0	0	1	1	1	1	0	2	0	1	1	0	0	1	0	0	0	0	1	2	1	0	1	0	0	2	0	0	0	0	0	0	0	0	1	0	0	0	97	0.2136563876651982	liu	2.0	0	Patient137	1263	860	679	155	0.185851319	2250	0.096268104	0	lymph node	3.7	CR	772	772	189	6	0	Pembrolizumab	3	1	216	0	0	0	1	1	0	0	0	0	occult	na	Pembro	0	0	0	0.0	0.0	0	0	lymph node	3	-111	na	0.19	2.01	SRR10899826	206	137	895	4	0	0	0	1	0	1	3	3	16	15	6	Neither	0.6618357487922706
71	SRR10898129	2	SRR10898368	liu	Patient24		M	PD	1.0	137.0	1.0	31.0		SRR10899999							SRR10898129	melanoma	1.0	1.0	1.0	1.0	2	1.0	1.0	1.0	1.0	liu	0	0	1	1	0	0	1	0	0	1	1	0	1	0	0	2	1	1	1	1	1	2	1	1	1	2	0	1	0	0	1	1	2	1	1	1	0	0	2	1	0	0	1	1	0	1	0	0	1	2	0	1	1	2	0	0	1	0	1	1	0	0	0	0	1	1	1	0	0	1	0	1	1	1	1	2	1	2	0	2	0	1	1	1	1	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	0	0	2	0	0	1	0	0	1	1	0	2	1	0	1	0	0	0	0	1	0	0	0	1	1	0	0	1	1	0	1	0	1	0	0	0	1	1	1	1	1	0	1	2	0	0	0	0	1	0	1	2	0	0	0	1	1	0	1	0	1	0	0	0	1	0	1	0	1	1	1	0	0	0	0	0	0	0	0	1	2	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	1	1	0	1	0	1	2	0	0	1	1	0	0	1	123	0.2709251101321586	liu	1.0	1	Patient24	398	276	231	37	0.138059701	837	0.136561942	1	skin	1.3	PD	31	137	31	6	0	Nivolumab	3	1	334	1	0	1	1	1	1	0	1	1	occult	na	Nivolumab	1	0	1	0.0	0.0	0	2	skin	3	-40	301	0.63	3.26	SRR10898129	57	30	278	2	0	0	0	0	0	0	0	0	6	9	3	Interactors	0.5172413793103449
72	SRR10899123	0	SRR10899124	liu	Patient193		F	SD	0.0	659.0	1.0	476.0		SRR10900002							SRR10899123	melanoma	1.0	2.0	1.0	2.0	1	2.0	2.0	1.0	1.0	liu	1	0	0	0	0	0	2	1	2	0	2	0	0	1	0	2	0	0	1	1	0	1	1	1	0	0	0	0	0	0	1	1	0	1	0	1	0	1	1	0	0	0	0	0	0	1	0	1	1	2	2	1	1	2	0	0	0	0	0	0	0	0	2	0	2	1	0	0	0	2	0	0	1	0	1	1	0	0	0	1	0	0	1	2	0	0	2	0	0	0	0	1	2	0	0	1	1	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	2	1	1	0	1	1	0	0	0	0	0	2	1	0	0	0	1	0	1	1	1	0	0	0	1	0	0	0	1	1	0	1	0	0	2	0	2	2	0	2	1	0	0	1	1	1	0	1	1	0	1	0	0	0	1	1	0	0	1	2	0	0	0	0	0	0	1	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	2	1	0	1	1	0	1	0	0	1	0	2	2	0	0	1	2	0	0	0	2	0	0	0	0	115	0.2533039647577093	liu	2.0	0	Patient193	904	571	458	72	0.135849057	1570	0.178066367	0	skin	1.2	SD	476	659	98	12	1	Pembrolizumab	0	0	229	0	0	1	0	0	0	0	1	0	skin	unknown	MK3475	0	0	0	0.0	0.0	0	0	skin	3	-35	na	0.77	1.84	SRR10899123	104	111	604	3	0	0	0	0	1	1	2	2	12	20	5	Neither	1.0571428571428572
73	SRR10898362	2	SRR10898959	liu	Patient179		F	PR	0.0	653.0	1.0	336.0		SRR10900570							SRR10898362	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	1	1	0	0	0	1	0	1	0	1	2	0	1	0	0	0	1	1	1	0	1	0	0	1	2	1	1	0	1	0	0	1	0	0	0	0	0	2	0	0	1	0	1	0	0	1	0	0	2	0	2	2	0	0	0	0	0	0	1	0	0	1	0	0	1	1	0	0	1	0	0	0	1	1	1	0	0	1	1	0	0	0	1	0	0	1	0	1	1	0	0	1	1	1	0	0	1	1	2	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	2	1	1	0	1	1	0	0	1	0	0	1	0	1	1	0	1	2	1	1	0	1	1	1	0	1	1	1	0	0	1	0	2	0	1	0	1	1	0	0	1	1	1	0	0	1	1	1	0	2	1	0	0	0	0	0	0	0	1	1	0	1	0	0	1	1	1	0	1	1	0	0	0	1	0	0	2	1	0	0	0	1	1	0	0	0	1	0	0	0	0	0	1	1	2	1	1	1	1	0	0	0	1	1	2	0	1	1	1	1	1	122	0.2687224669603524	liu	2.0	1	Patient179	729	478	407	65	0.137711864	1485	0.125244494	0	lymph node	7.233333333	PR	336	653	83	16	0	Pembrolizumab	2	0	173	0	0	0	0	1	0	0	1	0	skin	NM	MK3475	0	0	0	0.0	0.0	0	0	lymph node	3	-217	na	0.84	1.98	SRR10898362	132	44	475	2	0	2	0	1	1	0	0	0	6	13	1	Interactors	0.3308270676691729
74	SRR10899118	3	SRR10898294	liu	Patient187		F	CR	0.0	617.0	0.0	617.0		SRR10899988							SRR10899118	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	0	0	2	0	1	0	1	0	0	1	2	2	0	0	1	1	2	0	0	0	0	0	0	1	2	1	2	1	0	2	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	1	0	1	1	1	2	2	0	1	2	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1	1	2	0	0	0	0	0	2	0	1	0	2	0	0	0	1	0	1	0	0	0	2	1	0	0	2	0	2	1	0	1	1	1	0	0	0	0	0	0	0	1	0	2	0	0	0	0	0	0	0	1	0	0	0	0	0	0	2	0	0	0	0	2	0	0	1	1	0	0	1	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	2	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	1	2	2	0	0	0	2	0	0	0	0	2	0	0	1	1	1	0	0	1	2	0	0	0	2	0	0	0	0	2	0	1	0	0	0	1	0	2	1	0	0	1	2	1	109	0.2400881057268722	liu	2.0	0	Patient187	196	133	106	23	0.178294574	328	0.160872322	0	skin	1.166666667	CR	617	617	48	30	1	Pembrolizumab	1	0	193	0	0	1	0	0	0	0	0	0	skin	SSM	Pembro	0	1	1	0.0	0.0	0	3	skin	3	-35	687	0.75	2.1	SRR10899118	42	18	181	2	0	1	0	0	1	0	0	0	1	5	1	HLA	0.4186046511627907
75	SRR10899812	2	SRR10899900	liu	Patient125		M	CR	0.0	978.0	0.0	978.0		SRR10842377							SRR10899812	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	1	0	0	1	0	0	0	1	1	0	1	0	0	0	0	2	0	0	1	1	0	1	2	1	1	0	0	0	1	0	0	0	0	1	0	1	2	1	2	0	0	1	0	0	0	1	0	0	1	1	0	0	1	0	0	0	1	1	0	0	0	0	1	1	0	0	1	2	1	1	2	1	1	1	1	0	1	0	0	0	0	2	0	0	1	0	1	2	0	0	0	0	0	1	1	0	0	0	1	1	0	0	0	0	0	1	0	0	1	0	0	0	0	2	1	1	0	2	0	0	1	2	1	0	2	1	0	0	1	1	0	0	2	0	1	1	0	2	0	0	0	0	1	0	1	1	0	1	2	0	0	1	1	0	1	2	0	1	1	0	0	1	0	0	0	0	1	0	2	1	1	0	0	0	1	1	0	1	0	0	2	2	1	0	0	1	0	0	1	0	0	0	0	2	1	0	1	0	0	1	0	0	1	0	1	0	0	0	2	0	2	1	0	0	0	0	0	0	1	1	1	0	1	1	1	0	0	123	0.2709251101321586	liu	2.0	0	Patient125	97	57	40	7	0.14893617	92	0.018852639	1	skin	0.2	CR	978	978	76	26	0	Nivolumab	3	x	248	0	0	1	1	0	1	0	0	0	skin	superficial spreading	Nivolumab	1	1	0	0.0	0.0	0	0	skin	3	-6	na	0.1	2.13	SRR10899812	24	9	136	0	0	0	0	0	1	0	0	0	3	6	0	HLA	0.36
76	SRR10899814	2	SRR10899838	liu	Patient132		M	CR	0.0	739.0	1.0	389.0		SRR10842376							SRR10899814	melanoma	2.0	2.0	2.0	2.0	1	2.0	2.0	2.0	2.0	liu	0	0	0	0	0	1	0	1	1	0	1	0	0	1	1	1	0	0	2	0	0	1	0	0	0	0	0	1	1	0	2	1	0	1	0	1	0	0	1	1	0	0	0	0	0	1	0	0	0	2	0	0	1	1	2	1	0	0	0	0	0	0	1	0	1	1	1	0	0	0	0	1	0	1	0	1	0	0	0	0	0	1	1	1	0	0	1	0	0	2	0	1	1	1	0	1	1	0	2	0	0	1	0	0	0	0	0	1	0	0	0	1	1	1	0	0	1	0	1	0	1	1	0	0	2	1	2	2	1	1	1	0	0	1	1	0	0	0	2	0	0	0	2	2	0	0	1	1	1	0	1	0	1	0	0	0	1	1	1	0	1	0	0	0	1	0	1	0	0	1	1	2	1	0	0	0	0	0	0	2	0	0	1	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	1	0	0	1	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	1	0	0	1	0	0	0	2	0	105	0.2312775330396475	liu	2.0	0	Patient132	961	630	598	17	0.027642276	2078	0.129693461	1	lung	0.6	CR	389	739	87	18	0	Pembrolizumab	2	0	192	0	0	0	0	1	0	0	1	0	skin	nodular	Pembro	0	0	0	0.0	0.0	0	0	lung	3	-18	na	0.23	3.66	SRR10899814	198	73	641	3	1	0	1	1	1	0	2	2	15	16	1	HLA	0.36683417085427134
77	SRR10899114	2	SRR10898311	liu	Patient189		F	PR	0.0	718.0	1.0	406.0		SRR10899982							SRR10899114	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	1	2	0	2	0	0	0	1	0	2	0	0	1	1	1	1	2	1	0	1	0	1	0	1	0	1	0	0	0	0	0	0	0	0	1	2	1	1	1	1	0	0	0	0	0	1	0	0	0	1	1	1	0	0	1	0	0	0	1	0	0	1	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	1	2	1	0	1	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	1	0	0	2	1	0	2	1	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	1	2	1	0	0	2	1	1	0	0	1	1	0	0	0	0	1	1	0	1	0	0	0	0	0	0	1	1	0	2	1	0	0	0	1	0	0	0	1	0	1	2	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	2	0	0	0	0	1	2	1	0	0	0	1	0	0	0	2	1	0	1	0	0	2	0	0	1	1	0	1	0	0	2	0	0	0	103	0.2268722466960352	liu	2.0	1	Patient189	68	50	32	14	0.304347826	134	0.197113039	0	skin	3.8	PR	406	718	267	9	0	Pembrolizumab	3	1	275	1	0	0	1	0	0	0	1	0	acral	unknown	MK3475	0	0	0	0.0	0.0	0	0	skin	3	-115	na	0.19	2.23	SRR10899114	7	6	80	0	0	0	0	0	0	0	0	0	2	2	3	Interactors	0.75
78	SRR10868929	3	SRR10842351	liu	Patient107		M	PR	1.0	47.0	1.0	47.0		SRR10842358							SRR10868929	melanoma	2.0	2.0	1.0	2.0	1	2.0	2.0	2.0	1.0	liu	0	2	1	1	0	0	0	0	0	0	1	0	0	0	0	1	0	0	1	1	0	0	2	2	0	1	0	0	0	0	1	1	1	0	0	0	0	0	1	0	0	0	0	0	0	2	0	0	2	0	0	1	2	1	0	0	1	2	0	1	0	0	0	0	1	1	1	2	1	0	2	0	2	1	2	0	0	2	0	1	0	2	2	1	0	0	0	1	1	0	0	0	1	1	0	0	0	0	1	0	0	0	0	1	0	0	0	0	1	1	0	0	0	0	1	0	1	1	1	1	0	0	0	0	0	0	0	0	1	2	1	0	0	0	1	2	0	0	0	1	0	1	0	0	0	1	2	1	0	0	1	0	2	1	1	2	1	0	0	1	1	1	0	1	0	0	0	0	0	1	0	1	0	0	0	1	0	1	0	1	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	2	1	0	1	0	1	1	0	0	0	1	0	0	1	1	1	0	0	1	2	0	0	0	0	0	1	1	0	0	0	111	0.2444933920704846	liu	2.0	0	Patient107	247	158	133	20	0.130718954	489	0.144822308	1	adrenal gland	4.4	PR	47	47	29	1	0	Pembrolizumab	3	0	254	1	0	1	1	0	0	0	1	1	skin	unkown	MK3475	0	0	0	0.0	0.0	0	0	liver/visceral	3	-132	na	0.76	5.08	SRR10868929	50	10	150	2	0	0	0	0	1	0	1	1	2	6	0	HLA	0.19607843137254902
